Saratoga Investment
SAR
#7771
Rank
$0.37 B
Marketcap
$22.84
Share price
1.96%
Change (1 day)
-2.23%
Change (1 year)

Saratoga Investment - 10-Q quarterly report FY


Text size:
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

xQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended May 31, 2015

 

¨Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-33376

 

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 20-8700615
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)

 

535 Madison Avenue
New York, New York
 10022
(Address of principal executive office) (Zip Code)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large Accelerated Filer ¨  Accelerated Filer ¨
Non-Accelerated Filer x  Smaller Reporting Company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of July 14, 2015 was 5,588,754.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

 

 

     Page 

PART I

 FINANCIAL INFORMATION   3  

Item 1.

 Financial Statements   3  
 Consolidated Statements of Assets and Liabilities as of May 31, 2015 (unaudited) and February 28, 2015   3  
 Consolidated Statements of Operations for the three months ended May 31, 2015 and May 31, 2014 (unaudited)   4  
 Consolidated Schedules of Investments as of May 31, 2015 (unaudited) and February 28, 2015   5  
 Consolidated Statements of Changes in Net Assets for the three months ended May 31, 2015 and May 31, 2014 (unaudited)   11  
 Consolidated Statements of Cash Flows for the three months ended May 31, 2015 and May 31, 2014 (unaudited)   12  
 Notes to Consolidated Financial Statements as of May 31, 2015 (unaudited)   13  

Item 2.

 Management’s Discussion and Analysis of Financial Condition and Results of Operations   35  

Item 3.

 Quantitative and Qualitative Disclosures About Market Risk   55  

Item 4.

 Controls and Procedures   55  

PART II

 OTHER INFORMATION   56  

Item 1.

 Legal Proceedings   56  

Item 1A.

 Risk Factors   56  

Item 2.

 Unregistered Sales of Equity Securities and Use of Proceeds   56  

Item 3.

 Defaults upon Senior Securities   56  

Item 4.

 Mine Safety Disclosures   56  

Item 5.

 Other Information   56  

Item 6.

 Exhibits   57  

Signatures

    58  

 

2


Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

   As of 
   May 31, 2015  February 28, 2015 
   (unaudited)    

ASSETS

   

Investments at fair value

   

Non-control/non-affiliate investments (amortized cost of $239,950,830 and $222,505,383, respectively)

  $245,883,731   $223,506,589  

Control investments (cost of $15,172,837 and $15,953,001, respectively)

   16,860,256    17,031,146  
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $255,123,667 and $238,458,384, respectively)

   262,743,987    240,537,735  

Cash and cash equivalents

   699,127    1,888,158  

Cash and cash equivalents, reserve accounts

   5,863,893    18,175,214  

Interest receivable, (net of reserve of $354,144 and $309,498, respectively)

   2,793,526    2,469,398  

Management fee receivable

   174,527    171,913  

Other assets

   475,257    317,637  
  

 

 

  

 

 

 

Total assets

  $272,750,317   $263,560,055  
  

 

 

  

 

 

 

LIABILITIES

   

Revolving credit facility

  $11,800,000   $9,600,000  

Deferred debt financing costs, revolving credit facility

   (575,002  (594,845

SBA debentures payable

   79,000,000    79,000,000  

Deferred debt financing costs, SBA debentures payable

   (2,231,653  (2,340,894

Notes payable

   48,300,000    48,300,000  

Deferred debt financing costs, notes payable

   (1,758,989  (1,847,564

Dividend payable

   5,995,489    402,200  

Base management and incentive fees payable

   6,765,317    5,835,941  

Accounts payable and accrued expenses

   675,383    835,189  

Interest and debt fees payable

   912,628    1,405,466  

Due to manager

   375,820    365,820  
  

 

 

  

 

 

 

Total liabilities

  $149,258,993   $140,961,313  
  

 

 

  

 

 

 

Commitments and contingencies (See Note 7)

   

NET ASSETS

   

Common stock, par value $.001, 100,000,000 common shares authorized, 5,428,758 and 5,401,899 common shares issued and outstanding, respectively

  $5,429   $5,402  

Capital in excess of par value

   185,279,853    184,877,680  

Distribution in excess of net investment income

   (29,029,436  (23,905,603

Accumulated net realized loss from investments and derivatives

   (40,384,842  (40,458,088

Accumulated net unrealized appreciation on investments and derivatives

   7,620,320    2,079,351  
  

 

 

  

 

 

 

Total net assets

   123,491,324    122,598,742  
  

 

 

  

 

 

 

Total liabilities and net assets

  $272,750,317   $263,560,055  
  

 

 

  

 

 

 

NET ASSET VALUE PER SHARE

  $22.75   $22.70  
  

 

 

  

 

 

 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

   For the three months ended
May 31, 2015
  For the three months ended
May 31, 2014
 

INVESTMENT INCOME

   

Interest from investments

   

Non-control/Non-affiliate investments

  $5,648,979   $4,707,894  

Payment-in-kind interest income from Non-control/Non-affiliate investments

   691,152    252,928  

Control investments

   590,990    641,338  
  

 

 

  

 

 

 

Total interest income

   6,931,121    5,602,160  

Interest from cash and cash equivalents

   736    594  

Management fee income

   378,746    392,034  

Other income

   250,564    149,335  
  

 

 

  

 

 

 

Total investment income

   7,561,167    6,144,123  
  

 

 

  

 

 

 

EXPENSES

   

Interest and debt financing expenses

   1,963,865    1,787,587  

Base management fees

   1,124,098    968,479  

Professional fees

   333,444    435,374  

Administrator expenses

   250,000    250,000  

Incentive management fees

   1,797,833    378,489  

Insurance

   87,317    84,487  

Directors fees and expenses

   51,000    53,175  

General & administrative

   182,920    123,626  
  

 

 

  

 

 

 

Total expenses

   5,790,477    4,081,217  
  

 

 

  

 

 

 

NET INVESTMENT INCOME

   1,770,690    2,062,906  
  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

   

Net realized gain from investments

   73,246    81,680  

Net unrealized appreciation/(depreciation) on investments

   5,540,969    (384,697
  

 

 

  

 

 

 

Net gain/(loss) on investments

   5,614,215    (303,017
  

 

 

  

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $7,384,905   $1,759,889  
  

 

 

  

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $1.36   $0.33  

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING - BASIC AND DILUTED

   5,422,491    5,379,616  

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

May 31, 2015

(unaudited)

 

Company

 

Industry

 

Investment Interest Rate /

Maturity

 Principal/
Number
of Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments—199.1% (b)

    

National Truck Protection Co., Inc. (d), (g)

 Automotive Aftermarket   Common Stock  1,116   $1,000,000   $1,430,192    1.2

National Truck Protection Co., Inc. (d)

 Automotive Aftermarket First Lien Term Loan 15.50% Cash, 9/13/2018 $7,326,770    7,326,770    7,326,770    5.9

Take 5 Oil Change, L.L.C. (d), (g)

 Automotive Aftermarket Common Stock  7,128    480,535    1,782,855    1.4
    

 

 

  

 

 

  

 

 

 
  Total Automotive Aftermarket   8,807,305    10,539,817    8.5
    

 

 

  

 

 

  

 

 

 

Legacy Cabinets Holdings (d), (g)

 Building Products Common Stock Voting A-1  2,535    220,900    1,701,441    1.4

Legacy Cabinets Holdings (d), (g)

 Building Products Common Stock Voting B-1  1,600    139,424    1,073,888    0.9

Polar Holding Company, Ltd. (a), (i)

 Building Products First Lien Term Loan 10.00% Cash, 8/13/2016 $1,000,000    1,000,000    1,000,000    0.8
    

 

 

  

 

 

  

 

 

 
  Total Building Products   1,360,324    3,775,329    3.1
    

 

 

  

 

 

  

 

 

 

BMC Software, Inc. (d)

 Business Services First Lien Term Loan 5.00% Cash, 9/10/2020 $5,716,667    5,673,479    5,610,337    4.5

Dispensing Dynamics International (d)

 Business Services Senior Secured Note 12.50% Cash, 1/1/2018 $7,000,000    6,916,888    7,350,000    6.0

Easy Ice, LLC (d)

 Business Services First Lien Term Loan 9.50% Cash, 1/15/2020 $12,000,000    11,876,875    12,000,000    9.6

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note 10.00% Cash, 1/23/2020 $8,400,000    8,271,383    8,400,000    6.8

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests  49,318    400,000    452,056    0.4

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

 Business Services First Lien Term Loan 5.50% Cash, 6/28/2019 $1,950,101    1,937,220    1,940,351    1.6

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

 Business Services Second Lien Term Loan 9.50% Cash, 6/28/2020 $2,000,000    1,976,757    1,965,000    1.6

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan 11.00% Cash, 11/29/2017 $5,259,171    5,209,053    5,259,171    4.3

Knowland Technology Holdings, L.L.C. (j), (k), (l)

 Business Services Delayed Draw Term Loan 11.00% Cash, 11/29/2017 $—      —      —      0.0

Vector Controls Holding Co., LLC (d)

 Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $9,482,677    9,366,186    9,482,677    7.7

Vector Controls Holding Co., LLC (d), (g)

 Business Services Warrants to Purchase Limited Liability Company Interests  101    —      34,939    0.0
    

 

 

  

 

 

  

 

 

 
  Total Business Services   51,627,841    52,494,531    42.5
    

 

 

  

 

 

  

 

 

 

Targus Group International, Inc. (d)

 Consumer Products First Lien Term Loan, 14.75% (13.75% Cash/1.00% PIK), 5/24/2016 $3,577,302    3,551,526    3,035,341    2.5

Targus Holdings, Inc. (d), (g)

 Consumer Products Common Stock  62,413    566,765    —      0.0

Targus Holdings, Inc. (d), (m)

 Consumer Products Unsecured Note 10.00% PIK, 6/14/2019 $2,054,158    2,054,158    —      0.0

Targus Holdings, Inc. (d), (m)

 Consumer Products Unsecured Note 16.00% PIK, 10/26/2018 $429,797    425,459    —      0.0
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   6,597,908    3,035,341    2.5
    

 

 

  

 

 

  

 

 

 

Avionte Holdings, LLC (g)

 Consumer Services Common Stock  100,000    100,000    164,000    0.1

Avionte Holdings, LLC

 Consumer Services First Lien Term Loan 9.75% Cash, 1/8/2019 $2,406,342    2,370,166    2,406,342    1.9

Avionte Holdings, LLC (j), (l)

 Consumer Services Delayed Draw Term Loan A 9.75% Cash, 1/8/2019 $—      —      —      0.0

CFF Acquisition L.L.C. (d)

 Consumer Services First Lien Term Loan 7.50% Cash, 7/31/2015 $582,304    581,685    582,304    0.5

Expedited Travel L.L.C. (g)

 Consumer Services Common Stock  1,000,000    1,000,000    1,180,000    1.0

Expedited Travel L.L.C.

 Consumer Services First Lien Term Loan 10.00% Cash, 10/10/2019 $13,018,475    12,898,361    13,018,475    10.6

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan 6.50% Cash, 7/1/2019 $1,629,032    1,617,017    1,625,448    1.3

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan 9.75% Cash, 7/1/2020 $10,000,000    9,958,335    10,000,000    8.1
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   28,525,564    28,976,569    23.5
    

 

 

  

 

 

  

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

 Education Class A Common Stock  544,761    30,241    —      0.0

M/C Acquisition Corp., L.L.C. (d)

 Education First Lien Term Loan 1.00% Cash, 3/31/2016 $2,362,978    1,235,695    102,983    0.1
    

 

 

  

 

 

  

 

 

 
  Total Education   1,265,936    102,983    0.1
    

 

 

  

 

 

  

 

 

 

 

5


Table of Contents

Group Dekko, Inc. (d)

 Electronics Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016 $6,880,696    6,880,696    6,575,881    5.3
    

 

 

  

 

 

  

 

 

 
  Total Electronics   6,880,696    6,575,881    5.3
    

 

 

  

 

 

  

 

 

 

TB Corp. (d)

 Food and Beverage First Lien Term Loan 5.50% Cash, 6/19/2018 $4,992,403    4,981,077    4,973,931    4.0

TB Corp. (d)

 Food and Beverage Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018 $2,546,121    2,513,305    2,546,121    2.1

TM Restaurant Group L.L.C.

 Food and Beverage First Lien Term Loan 9.75% Cash, 7/16/2017 $9,783,298    9,649,729    9,764,709    7.9
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   17,144,111    17,284,761    14.0
    

 

 

  

 

 

  

 

 

 

Bristol Hospice, LLC

 Healthcare Services Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018 $5,445,486    5,365,513    5,445,486    4.5

Bristol Hospice, LLC (j), (l)

 Healthcare Services Delayed Draw Term Loan 11.00% (10.00% Cash/1.00% PIK), 11/29/2018 $—      —      —      0.0

Roscoe Medical, Inc. (d), (g)

 Healthcare Services Common Stock  5,000    500,000    328,400    0.3

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000    4,132,667    4,009,740    3.2

Smile Brands Group Inc. (d)

 Healthcare Services First Lien Term Loan 7.50% Cash, 8/16/2019 $4,432,500    4,365,682    3,745,463    3.0

Surgical Specialties Corporation (US), Inc. (d)

 Healthcare Services First Lien Term Loan 7.25% Cash, 8/22/2018 $2,263,197    2,247,736    2,240,565    1.8

Zest Holdings, LLC (d)

 Healthcare Services First Lien Term Loan 5.25% Cash, 8/16/2020 $4,241,318    4,166,205    4,257,435    3.4
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   20,777,803    20,027,089    16.2
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 12.00% Cash, 5/16/2019 $9,294,607    9,141,763    9,410,790    7.7

HMN Holdco, LLC (j), (k)

 Media Deferred Draw Term Loan 12.00% Cash, 5/16/2020 $1,600,000    1,569,588    1,620,000    1.3

HMN Holdco, LLC (g)

 Media Class A Series  4,264    61,647    247,525    0.2

HMN Holdco, LLC (g)

 Media Class A Warrant  30,320    438,353    1,415,034    1.1

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common)  57,872    —      2,404,582    1.9

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests  8,139    —      395,637    0.3
    

 

 

  

 

 

  

 

 

 
  Total Media   11,211,351    15,493,568    12.5
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

 Metals Common Stock  35,000    9,217,563    6,762,000    5.5

Elyria Foundry Company, L.L.C. (d)

 Metals Revolver 9.50% Cash, 12/31/2020 $8,500,000    8,500,000    8,500,000    6.9
    

 

 

  

 

 

  

 

 

 
  Total Metals   17,717,563    15,262,000    12.4
    

 

 

  

 

 

  

 

 

 

Network Communications, Inc. (d), (g)

 Publishing Common Stock  380,572    —      3,206,314    2.6

Network Communications, Inc. (d)

 Publishing Unsecured Notes 8.60% PIK, 1/14/2020 $3,214,368    2,867,573    3,214,368    2.6
    

 

 

  

 

 

  

 

 

 
  Total Publishing   2,867,573    6,420,682    5.2
    

 

 

  

 

 

  

 

 

 

Censis Technologies, Inc.

 Software as a Service First Lien Term Loan B 11.00% Cash, 7/24/2019 $11,775,000    11,570,813    11,775,000    9.5

Censis Technologies, Inc. (g), (h)

 Software as a Service Limited Partner Interests  999    999,000    988,011    0.8

Community Investors, Inc. (g)

 Software as a Service Common Stock  1,282    1,282    2,546    0.0

Community Investors, Inc.

 Software as a Service First Lien, Last Out Term Loan 11.73% Cash, 9/30/2019 $12,000,000    12,000,000    12,000,000    9.7

Community Investors, Inc.

 Software as a Service First Lien Term Loan B 12.20% Cash, 12/31/2020 $2,500,000    2,500,000    2,500,000    2.0

Community Investors, Inc. (g)

 Software as a Service Preferred Stock  63,463    149,138    126,056    0.1

Community Investors, Inc. (g)

 Software as a Service Preferred Stock - A Shares  135,584    135,584    269,309    0.2

Community Investors, Inc.

 Software as a Service Unsecured Note 10.00% PIK, 3/20/2020 $100,853    100,853    100,853    0.1

Finalsite Holdings, Inc.

 Software as a Service Second Lien Term Loan 10.25% Cash, 11/21/2019 $7,500,000    7,435,282    7,500,000    6.1

Identity Automation Systems (g)

 Software as a Service Common Stock Class A Units  232,616    232,616    227,964    0.2

Identity Automation Systems

 Software as a Service First Lien Term Loan 10.25% Cash, 8/25/2019 $4,450,000    4,410,898    4,450,000    3.6

Mercury Network, LLC

 Software as a Service First Lien Term Loan    
  10.25% Cash, 4/20/2020 $9,086,957    8,998,663    9,086,957    7.4

Mercury Network, LLC (g)

 Software as a Service Common Stock  413,043    413,043    413,043    0.3

Pen-Link, Ltd. (d)

 Software as a Service Second Lien Term Loan 12.50% Cash, 5/26/2019 $10,500,000    10,334,109    10,500,000    8.5
    

 

 

  

 

 

  

 

 

 
  Total Software as a Service   59,281,281    59,939,739    48.5
    

 

 

  

 

 

  

 

 

 

 

6


Table of Contents

Advanced Air & Heat of Florida, LLC

 Utilities First Lien Term Loan 10.00% Cash, 1/31/2019 $5,955,441    5,885,574    5,955,441    4.8
    

 

 

  

 

 

  

 

 

 
  Total Utilities   5,885,574    5,955,441    4.8
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

   239,950,830    245,883,731    199.1
    

 

 

  

 

 

  

 

 

 

Control investments - 13.7% (b)

      

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

 Structured Finance Securities Other/Structured Finance Securities 16.21%, 10/17/2023 $30,000,000    15,172,837    16,860,256    13.7
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

     15,172,837    16,860,256    13.7
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 212.8% (b)

   $255,123,667   $262,743,987    212.8
    

 

 

  

 

 

  

 

 

 

 

(a)Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 6.8% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $123,491,324 as of May 31, 2015.
(c)Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d)These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 16.21% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

  Purchases   Redemptions   Sales
(cost)
   Interest
Income
   Management
fee income
   Net Realized
gains/(losses)
   Net Unrealized
gains
 

Saratoga Investment Corp. CLO
2013-1, Ltd.

  $—      $—      $—      $590,990    $378,746    $—      $1,687,419  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g)Non-income producing at May 31, 2015.
(h)Includes securities issued by an affiliate of the company.
(i)Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j)The investment has an unfunded commitment as of May 31, 2015 (See note 7).
(k)Includes an analysis of the fair value of any unfunded loan commitments.
(l)The entire commitment was unfunded at May 31, 2015. As such, no interest is being earned on this investment.
(m)The investment was on non-accrual status as of May 31, 2015.

 

7


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2015

 

Company

 

Industry

 

Investment Interest Rate /

Maturity

 Principal/
Number
of Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments - 182.3% (b)

    

National Truck Protection Co., Inc. (d), (g)

 Automotive Aftermarket Common Stock  1,116   $1,000,000   $1,769,432    1.4

National Truck Protection Co., Inc. (d)

 Automotive Aftermarket First Lien Term Loan 15.50% Cash, 9/13/2018 $7,737,848    7,737,848    7,737,848    6.3

Take 5 Oil Change, L.L.C. (d), (g)

 Automotive Aftermarket Common Stock  7,128    480,535    1,472,502    1.2
    

 

 

  

 

 

  

 

 

 
  Total Automotive Aftermarket   9,218,383    10,979,782    8.9
    

 

 

  

 

 

  

 

 

 

Legacy Cabinets Holdings (d), (g)

 Building Products Common Stock Voting A-1  2,535    220,900    1,493,470    1.2

Legacy Cabinets Holdings (d), (g)

 Building Products Common Stock Voting B-1  1,600    139,424    942,624    0.8

Polar Holding Company, Ltd. (a), (i)

 Building Products First Lien Term Loan 10.00% Cash, 8/13/2016 $1,000,000    1,000,000    1,000,000    0.8
    

 

 

  

 

 

  

 

 

 
  Total Building Products   1,360,324    3,436,094    2.8
    

 

 

  

 

 

  

 

 

 

BMC Software, Inc. (d)

 Business Services First Lien Term Loan 5.00% Cash, 9/10/2020 $5,731,667    5,686,622    5,478,327    4.5

Dispensing Dynamics International (d)

 Business Services Senior Secured Note 12.50% Cash, 1/1/2018 $7,000,000    6,910,112    7,350,000    6.0

Easy Ice, LLC (d)

 Business Services First Lien Term Loan 9.50% Cash, 1/15/2020 $12,000,000    11,872,639    12,000,000    9.6

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note 10.00% Cash, 1/23/2020 $8,400,000    8,260,787    8,400,000    6.9

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests  49,318    400,000    391,584    0.3

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

 Business Services First Lien Term Loan 5.50% Cash, 6/28/2019 $1,955,051    1,941,417    1,925,725    1.6

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

 Business Services Second Lien Term Loan 9.50% Cash, 6/28/2020 $2,000,000    1,975,767    1,965,000    1.6

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan 11.00% Cash, 11/29/2017 $5,259,171    5,205,142    5,259,171    4.3

Knowland Technology Holdings, L.L.C. (j), (k), (l)

 Business Services Delayed Draw Term Loan 11.00% Cash, 11/29/2017 $—      —      —      0.0

Vector Controls Holding Co., LLC (d)

 Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $9,436,991    9,312,095    9,295,437    7.6

Vector Controls Holding Co., LLC (d), (g)

 Business Services Warrants to Purchase Limited Liability Company Interests  101    —      62,341    0.1
    

 

 

  

 

 

  

 

 

 
  Total Business Services   51,564,581    52,127,585    42.5
    

 

 

  

 

 

  

 

 

 

Targus Group International, Inc. (d)

 Consumer Products First Lien Term Loan, 12.00% (11.00% Cash/1.00% PIK), 5/24/2016 $3,569,127    3,537,732    3,283,597    2.7

Targus Holdings, Inc. (d), (g)

 Consumer Products Common Stock  62,413    566,765    —      0.0

Targus Holdings, Inc. (d), (g)

 Consumer Products Unsecured Note 10.00% PIK, 6/14/2019 $2,054,158    2,054,158    —      0.0

Targus Holdings, Inc. (d), (g)

 Consumer Products Unsecured Note 16.00% PIK, 10/26/2018 $429,797    425,227    —      0.0
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   6,583,882    3,283,597    2.7
    

 

 

  

 

 

  

 

 

 

Avionte Holdings, LLC (g)

 Consumer Services Common Stock  100,000    100,000    163,000    0.1

Avionte Holdings, LLC

 Consumer Services First Lien Term Loan 9.75% Cash, 1/8/2019 $3,000,000    2,951,759    3,000,000    2.4

Avionte Holdings, LLC (j), (l)

 Consumer Services Delayed Draw Term Loan A 9.75% Cash, 1/8/2019 $—      —      —      0.0

CFF Acquisition L.L.C. (d)

 Consumer Services First Lien Term Loan 7.50% Cash, 7/31/2015 $716,179    714,270    716,179    0.6

Expedited Travel L.L.C. (g)

 Consumer Services Common Stock  1,000,000    1,000,000    1,069,157    0.9

Expedited Travel L.L.C.

 Consumer Services First Lien Term Loan 10.00% Cash, 10/10/2019 $13,750,000    13,609,579    13,750,000    11.2

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan 6.25% Cash, 7/1/2019 $3,709,677    3,680,863    3,652,919    3.0

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan 9.75% Cash, 7/1/2020 $5,000,000    4,937,212    4,981,000    4.1
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   26,993,683    27,332,255    22.3
    

 

 

  

 

 

  

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

 Education Class A Common Stock  544,761    30,241    —      0.0

M/C Acquisition Corp., L.L.C. (d)

 Education First Lien Term Loan 1.00% Cash, 3/31/2015 $2,362,978    1,235,695    100,951    0.1
    

 

 

  

 

 

  

 

 

 
  Total Education   1,265,936    100,951    0.1
    

 

 

  

 

 

  

 

 

 

Group Dekko, Inc. (d)

 Electronics Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016 $6,950,048    6,950,048    6,667,181    5.4
    

 

 

  

 

 

  

 

 

 
  Total Electronics   6,950,048    6,667,181    5.4
    

 

 

  

 

 

  

 

 

 

 

8


Table of Contents

TB Corp. (d)

 Food and Beverage First Lien Term Loan 5.76% Cash, 6/19/2018 $ 5,050,436    5,038,131    5,037,810    4.0

TB Corp. (d)

 Food and Beverage Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018 $2,546,121    2,512,732    2,546,121    2.1

TM Restaurant Group L.L.C.

 Food and Beverage First Lien Term Loan 7.75% Cash, 7/16/2017 $2,791,595    2,791,595    2,763,679    2.3
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   10,342,458    10,347,610    8.4
    

 

 

  

 

 

  

 

 

 

Bristol Hospice, LLC

 Healthcare Services Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018 $5,459,134    5,374,249    5,459,134    4.4

Bristol Hospice, LLC (j), (l)

 Healthcare Services Delayed Draw Term Loan 11.00% (10.00% Cash/1.00% PIK), 11/29/2018 $—      —      —      0.0

Roscoe Medical, Inc. (d), (g)

 Healthcare Services Common Stock  5,000    500,000    294,500    0.2

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000    4,129,704    3,990,000    3.3

Smile Brands Group Inc. (d)

 Healthcare Services First Lien Term Loan 7.50% Cash, 8/16/2019 $4,443,750    4,373,369    4,159,350    3.4

Surgical Specialties Corporation (US), Inc. (d)

 Healthcare Services First Lien Term Loan 7.25% Cash, 8/22/2018 $2,312,500    2,295,234    2,277,813    1.9

Zest Holdings, LLC (d)

 Healthcare Services First Lien Term Loan 5.25% Cash, 8/16/2020 $4,443,919    4,361,438    4,460,806    3.6
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   21,033,994    20,641,603    16.8
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 14.00% (12.00% Cash/2.00% PIK), 5/16/2019 $9,368,327    9,206,438    9,579,115    7.9

HMN Holdco, LLC

 Media First Lien Term Loan 12.00% Cash, 5/16/2020 $1,600,000    1,569,149    1,576,000    1.3

HMN Holdco, LLC (j), (k)

 Media Deferred Draw Term Loan 12.00% Cash, 5/16/2020 $—      —      (36,000  0.0

HMN Holdco, LLC (g)

 Media Class A Series  4,264    61,647    223,604    0.2

HMN Holdco, LLC (g)

 Media Class A Warrant  30,320    438,353    1,247,365    1.0

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common)  57,872    —      2,085,128    1.7

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests  8,139    —      350,464    0.3
    

 

 

  

 

 

  

 

 

 
  Total Media   11,275,587    15,025,676    12.4
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

 Metals Common Stock  35,000    9,217,563    6,762,000    5.5

Elyria Foundry Company, L.L.C. (d)

 Metals Revolver 9.00% Cash, 12/31/2020 $8,500,000    8,500,000    8,500,000    6.8
    

 

 

  

 

 

  

 

 

 
  Total Metals   17,717,563    15,262,000    12.3
    

 

 

  

 

 

  

 

 

 

Network Communications, Inc. (d), (g)

 Publishing Common Stock  380,572    —      300,652    0.2

Network Communications, Inc. (d)

 Publishing Unsecured Notes 8.60% PIK, 1/14/2020 $2,732,976    2,374,260    1,684,118    1.4
    

 

 

  

 

 

  

 

 

 
  Total Publishing   2,374,260    1,984,770    1.6
    

 

 

  

 

 

  

 

 

 

Censis Technologies, Inc.

 Software as a Service First Lien Term Loan B 11.00% Cash, 7/24/2019 $11,850,000    11,634,939    11,850,000    9.7

Censis Technologies, Inc. (g), (h)

 Software as a Service Limited Partner Interests  999    999,000    981,627    0.8

Community Investors, Inc. (g)

 Software as a Service Common Stock  1,282    1,282    1,769    0.0

Community Investors, Inc.

 Software as a Service First Lien, Last Out Term Loan 11.78% Cash, 9/30/2019 $12,000,000    12,000,000    12,000,000    9.7

Community Investors, Inc.

 Software as a Service First Lien Term Loan B 12.25% Cash, 12/31/2020 $2,500,000    2,500,000    2,500,000    2.0

Community Investors, Inc. (g)

 Software as a Service Preferred Stock  63,463    149,138    87,579    0.1

Community Investors, Inc.

 Software as a Service Preferred Stock - A2  38,641    100,853    53,325    0.0

Community Investors, Inc. (g)

 Software as a Service Preferred Stock - A Shares  135,584    135,584    187,106    0.2

Finalsite Holdings, Inc.

 Software as a Service Second Lien Term Loan 10.25% Cash, 11/21/2019 $7,500,000    7,429,305    7,500,000    6.1

Identity Automation Systems (g)

 Software as a Service Common Stock Class A Units  232,616    232,616    225,638    0.2

Identity Automation Systems

 Software as a Service First Lien Term Loan 10.25% Cash, 8/25/2019 $4,475,000    4,433,897    4,475,000    3.7

Pen-Link, Ltd. (d)

 Software as a Service Second Lien Term Loan 12.50% Cash, 5/26/2019 $10,500,000    10,326,376    10,500,000    8.6
    

 

 

  

 

 

  

 

 

 
  Total Software as a Service   49,942,990    50,362,044    41.1
    

 

 

  

 

 

  

 

 

 

Advanced Air & Heat of Florida, LLC

 Utilities First Lien Term Loan 10.00% Cash, 1/31/2019 $5,955,441    5,881,694    5,955,441    5.0
    

 

 

  

 

 

  

 

 

 
  Total Utilities   5,881,694    5,955,441    5.0
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

   222,505,383    223,506,589    182.3
    

 

 

  

 

 

  

 

 

 

Control investments - 13.9% (b)

      

 

9


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

 Structured Finance Securities Other/Structured Finance Securities 14.32%, 10/17/2023 $30,000,000    15,953,001    17,031,146    13.9
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

     15,953,001    17,031,146    13.9
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 196.2% (b)

    $238,458,384   $240,537,735    196.2
    

 

 

  

 

 

  

 

 

 

 

(a)Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 7.5% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $122,598,742, as of February 28, 2015.
(c)Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d)These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 14.32% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

  Purchases   Redemptions   Sales
(cost)
   Interest
Income
   Management
fee income
   Net Realized
gains/(losses)
   Net Unrealized
gains
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

  $—      $—      $—      $2,707,230    $1,520,205    $—      $1,078,145  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g)Non-income producing at February 28, 2015.
(h)Includes securities issued by an affiliate of the company.
(i)Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j)The investment has an unfunded commitment as of February 28, 2015 (See note 7).
(k)Includes an analysis of the value of any unfunded loan commitments.
(l)The entire commitment was unfunded at February 28, 2015. As such, no interest is being earned on this investment.

 

10


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

   For the three months ended
May 31, 2015
  For the three months ended
May 31, 2014
 

INCREASE FROM OPERATIONS:

   

Net investment income

  $1,770,690   $2,062,906  

Net realized gain from investments

   73,246    81,680  

Net unrealized appreciation (depreciation) on investments

   5,540,969    (384,697
  

 

 

  

 

 

 

Net increase in net assets from operations

 7,384,905   1,759,889  
  

 

 

  

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

Distributions declared

 (6,894,523 —    
  

 

 

  

 

 

 

Net decrease in net assets from shareholder distributions

 (6,894,523 —    
  

 

 

  

 

 

 

CAPITAL SHARE TRANSACTIONS:

Stock dividend distribution

 402,200   —    
  

 

 

  

 

 

 

Net increase in net assets from capital share transactions

 402,200   —    
  

 

 

  

 

 

 

Total increase in net assets

 892,582   1,759,889  

Net assets at beginning of period

 122,598,742   113,427,929  
  

 

 

  

 

 

 

Net assets at end of period

$123,491,324  $115,187,818  
  

 

 

  

 

 

 

Net asset value per common share

$22.75  $21.41  

Common shares outstanding at end of period

 5,428,758   5,379,616  

Distribution in excess of net investment income

$(29,029,436$(29,060,761

See accompanying notes to consolidated financial statements.

 

11


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

   For the three months ended
May 31, 2015
  For the three months ended
May 31, 2014
 

Operating activities

   

NET INCREASE IN NET ASSETS FROM OPERATIONS

  $7,384,905   $1,759,889  

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:

   

Paid-in-kind interest income

   (597,336  (110,592

Net accretion of discount on investments

   (143,205  (177,191

Amortization of deferred debt financing costs

   217,658    252,299  

Net realized gain from investments

   (73,246  (81,680

Net unrealized (appreciation) depreciation on investments

   (5,540,969  384,697  

Proceeds from sale and redemption of investments

   7,323,338    8,689,899  

Purchase of investments

   (23,174,833  (21,574,435

(Increase) decrease in operating assets:

   

Cash and cash equivalents, reserve accounts

   12,311,321    (6,432,500

Interest receivable

   (324,128  (934,623

Management fee receivable

   (2,614  (16,770

Other assets

   (4,847  (6,875

Increase (decrease) in operating liabilities:

   

Management and incentive fees payable

   929,376    (209,637

Accounts payable and accrued expenses

   (159,806  71,538  

Interest and debt fees payable

   (492,838  (214,866

Due to manager

   10,000    (50,000
  

 

 

  

 

 

 

NET CASH USED BY OPERATING ACTIVITIES

   (2,337,224  (18,650,847
  

 

 

  

 

 

 

Financing activities

   

Borrowings on debt

   3,200,000    18,700,000  

Paydowns on debt

   (1,000,000  —    

Debt financing cost

   (152,773  (368,940

Payments of cash dividends

   (899,034  —    
  

 

 

  

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

   1,148,193    18,331,060  
  

 

 

  

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

   (1,189,031  (319,787

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

   1,888,158    3,293,898  
  

 

 

  

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

  $699,127   $2,974,111  
  

 

 

  

 

 

 

Supplemental information:

   

Interest paid during the period

  $2,239,045   $1,750,155  

Supplemental non-cash information:

   

Paid-in-kind interest income

  $597,336   $110,592  

Net accretion of discount on investments

  $143,205   $177,191  

Amortization of deferred debt financing costs

  $217,658   $252,299  

Stock dividend distribution

  $402,200   $—    

See accompanying notes to consolidated financial statements.

 

12


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

May 31, 2015

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.”.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to the Management Agreement. Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiary, except as stated otherwise.

The Company and SBIC are both considered to be investment companies for financial reporting purposes and have applied the guidance in Topic 946, “Financial Services — Investment Companies”. There have been no changes to the Company or SBIC’s status as investment companies during the three months ended May 31, 2015.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

 

13


Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as a money market fund, if such investment would cause the Company to exceed any of the following limitations:

 

  we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

  we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

  we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

 

14


Table of Contents

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

  An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Derivative Financial Instruments

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging(“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes

 

15


Table of Contents

in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in income when earned.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

In April 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, and early adoption is allowed, and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. The adoption of the provisions of ASU 2015-03 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

 

16


Table of Contents

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2015, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2012, 2013 and 2014 federal tax years for the Company remain subject to examination by the IRS. As of May 31, 2015 and May 31, 2014, there were no uncertain tax positions.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains net of realized and unrealized losses for the period.

New Accounting Pronouncements

In February 2015, the FASB issued ASU 2015-02, Consolidation (ASC Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 significantly changes the consolidation analysis required under GAAP and ends the deferral granted to investment companies from applying the variable interest entity guidance. ASU 2015-02 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2015 and early adoption is permitted. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management is currently evaluating the impact of adopting this new accounting guidance update on the company’s consolidated financial statement.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition

 

17


Table of Contents

(Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2016, and early application is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

  Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

  Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

  Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

 

18


Table of Contents

The following table presents fair value measurements of investments, by major class, as of May 31, 2015 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—     $—     $17,794    $17,794  

First lien term loans

   —      —      157,072     157,072  

Second lien term loans

   —      —      40,551     40,551  

Unsecured notes

   —      —      5,861     5,861  

Structured finance securities

   —      —      16,860     16,860  

Equity interest

   —      —      24,606     24,606  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—     $—     $262,744    $262,744  
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2015 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—     $—     $18,302    $18,302  

First lien term loans

   —      —      145,207     145,207  

Second lien term loans

   —      —      35,603     35,603  

Unsecured notes

   —      —      4,230     4,230  

Structured finance securities

   —      —      17,031     17,031  

Equity interest

   —      —      20,165     20,165  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—     $—     $240,538    $240,538  
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2015 (dollars in thousands):

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Unsecured
notes
   Structured
finance
securities
  Common
stock/
equities
  Total 

Balance as of February 28, 2015

  $18,302   $145,207   $35,603   $4,230    $17,031   $20,165   $240,538  

Net unrealized gains (losses)

   (240  29    (22  1,036     609    4,129    5,541  

Purchases and other adjustments to cost

   11    17,941    5,056    494     —     413    23,915  

Sales and redemptions

   (283  (6,174  (86  —      (780  —      (7,323

Net realized gain from investments

   4    69    —      —      —     —      73  

Transfers in/out

   —     —      —     101    —     (101  —   
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

  

 

 

 

Balance as of May 31, 2015

  $17,794   $157,072   $40,551   $5,861    $16,860   $24,606   $262,744  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

  

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the three months ended May 31, 2015 on investments held as of May 31, 2015 is $5,493,439 and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

 

19


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2014 (dollars in thousands):

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Unsecured
notes
   Structured
finance
securities
   Common
stock/
equities
  Total 

Balance as of February 28, 2014

  $32,390   $110,278   $27,804   $5,471    $19,570    $10,332   $205,845  

Net unrealized gains (losses)

   (181  (342  (210  8     549     (209  (385

Purchases and other adjustments to cost

   16    9,605    11,134    76     —      1,031    21,862  

Sales and redemptions

   (106  (2,584  (6,000  —      —       —      (8,690

Net realized gain (loss) from investments

   1    35    46    —      —      —     82  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

   

 

 

  

 

 

 

Balance as of May 31, 2014

  $32,120   $116,992   $32,774   $5,555    $20,119    $11,154   $218,714  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

   

 

 

  

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the three months ended May 31, 2014 on investments held as of May 31, 2014 is ($319,092) and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of May 31, 2015 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input Range

Syndicated loans

   17,794    Market Comparables  Third-Party Bid 84.5% -100.4%

First lien term loans

   157,072    Market Comparables  Market Yield (%) 6.2% – 15.5%
      EBITDA Multiples (x) 0.1x – 3.0x
      Third-Party Bid 81.5% - 105.0%

Second lien term loans

   40,551    Market Comparables  Market Yield (%) 8.5% - 16.9%
      Third-Party Bid 99.5% - 100.0%

Unsecured notes

   5,861    Market Comparables  Market Yield (%) 8.6% - 13.2%

Structured finance securities

   16,860    Discounted Cash Flow  Discount Rate (%) 11.0%

Equity interests

   24,606    Market Comparables  EBITDA Multiples (x) 5.0x – 11.0x

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2015 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input Range

Syndicated loans

   18,302    Market Comparables  Third-Party Bid 93.6% -100.4%

First lien term loans

   145,207    Market Comparables  Market Yield (%) 5.8% - 17.7%
      EBITDA Multiples (x) 3.0x
      Third-Party Bid 79.3 - 105.0

Second lien term loans

   35,603    Market Comparables  Market Yield (%) 8.5% - 15.0%
      Third-Party Bid 98.3% - 98.3%

Unsecured notes

   4,230    Market Comparables  Market Yield (%) 13.2% - 20.3%

Structured finance securities

   17,031    Discounted Cash Flow  Discount Rate (%) 12.0%

Equity interests

   20,165    Market Comparables  EBITDA Multiples (x) 5.0x - 12.1x

 

20


Table of Contents

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of our investments as of May 31, 2015, at amortized cost and fair value were as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $18,390     7.2 $17,794     6.8

First lien term loans

   156,795     61.4    157,072     59.8  

Second lien term loans

   40,718     16.0    40,551     15.4  

Unsecured notes

   7,962     3.1    5,861     2.2  

Structured finance securities

   15,173     6.0    16,860     6.4  

Equity interest

   16,086     6.3    24,606     9.4  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $255,124     100.0 $262,744     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

The composition of our investments as of February 28, 2015, at amortized cost and fair value were as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $18,658     7.8 $18,302     7.6

First lien term loans

   144,959     60.8    145,207     60.3  

Second lien term loans

   35,748     15.0    35,603     14.8  

Unsecured notes

   7,366     3.1    4,230     1.8  

Structured finance securities

   15,953     6.7    17,031     7.1  

Equity interest

   15,774     6.6    20,165     8.4  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $238,458     100.0 $240,538     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

 

21


Table of Contents

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at May 31, 2015. The significant inputs for the valuation model include:

 

  Default rates: 2.0%

 

  Recovery rates: 35-75%

 

  Prepayment rate: 25.0%

 

  Reinvestment rate / price: L+375bps / $99.75

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the three months ended May 31, 2015 and May 31, 2014, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.6 million and $0.6 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At May 31, 2015, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $16.9 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At May 31, 2015, Saratoga CLO had investments with a principal balance of $306.6 million and a weighted average spread over LIBOR of 4.2%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At May 31, 2015, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $17.1 million, which had a present value of approximately $16.9 million, using an 11.0% discount rate.

Below is certain financial information from the separate unaudited financial statements of Saratoga CLO as of May 31, 2015 and February 28, 2015 and for the three months ended May 31, 2015 and May 31, 2014.

 

22


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

   As of 
   May 31, 2015  February 28, 2015 
   (unaudited)    

ASSETS

   

Investments

   

Fair Value Loans (amortized cost of $304,723,108, and $295,193,588, respectively)

  $304,192,066   $294,621,817  

Fair Value Other/Structured finance securities (amortized cost of $2,566,752 and $2,566,752, respectively)

   490,890    617,451  
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $307,289,860 and $297,760,340, respectively)

 304,682,956   295,239,268  

Cash and cash equivalents

 2,565,671   5,831,797  

Receivable from open trades

 745,005   2,119,687  

Interest receivable

 1,361,040   1,290,637  
  

 

 

  

 

 

 

Total assets

$309,354,672  $304,481,389  
  

 

 

  

 

 

 

LIABILITIES

Interest payable

$644,098  $631,886  

Payable from open trades

 9,759,881   5,214,331  

Accrued base management fee

 87,263   85,957  

Accrued subordinated management fee

 87,263   85,957  

Class A-1 Notes - SIC CLO 2013-1, Ltd.

 170,000,000   170,000,000  

Discount on Class A-1 Notes - SIC CLO 2013-1, Ltd.

 (1,451,425 (1,495,802

Class A-2 Notes - SIC CLO 2013-1, Ltd.

 20,000,000   20,000,000  

Discount on Class A-2 Notes - SIC CLO 2013-1, Ltd.

 (150,450 (155,050

Class B Notes - SIC CLO 2013-1, Ltd.

 44,800,000   44,800,000  

Discount on Class B Notes - SIC CLO 2013-1, Ltd.

 (977,323 (1,007,205

Class C Notes - SIC CLO 2013-1, Ltd.

 16,000,000   16,000,000  

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

 (608,487 (627,091

Class D Notes - SIC CLO 2013-1, Ltd.

 14,000,000   14,000,000  

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

 (789,863 (814,013

Class E Notes - SIC CLO 2013-1, Ltd.

 13,100,000   13,100,000  

Discount on Class E Notes - SIC CLO 2013-1, Ltd.

 (1,489,121 (1,534,650

Class F Notes - SIC CLO 2013-1, Ltd.

 4,500,000   4,500,000  

Discount on Class F Notes - SIC CLO 2013-1, Ltd.

 (541,620 (558,180

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

 (1,885,333 (1,941,595

Subordinated Notes

 30,000,000   30,000,000  
  

 

 

  

 

 

 

Total liabilities

$315,084,883  $310,284,545  
  

 

 

  

 

 

 

Commitments and contingencies

NET ASSETS

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

$250  $250  

Accumulated loss

 (5,803,406 (3,343,488

Net gain/(loss)

 72,945   (2,459,918
  

 

 

  

 

 

 

Total net assets

 (5,730,211 (5,803,156
  

 

 

  

 

 

 

Total liabilities and net assets

$309,354,672  $304,481,389  
  

 

 

  

 

 

 

 

23


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

   For the three months ended
May 31, 2015
  For the three months ended
May 31, 2014
 

INVESTMENT INCOME

   

Interest from investments

  $3,512,587   $3,157,518  

Interest from cash and cash equivalents

   290    276  

Other income

   164,115    98,923  
  

 

 

  

 

 

 

Total investment income

 3,676,992   3,256,717  
  

 

 

  

 

 

 

EXPENSES

Interest expense

 2,846,636   2,126,984  

Professional fees

 59,222   70,218  

Miscellaneous fee expense

 4,925   23,133  

Base management fee

 189,373   196,017  

Subordinated management fee

 189,373   196,017  

Trustee expenses

 31,284   26,615  

Amortization expense

 239,963   239,963  
  

 

 

  

 

 

 

Total expenses

 3,560,776   2,878,947  
  

 

 

  

 

 

 

NET INVESTMENT INCOME

 116,216   377,770  
  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain on investments

 42,561   380,619  

Net unrealized depreciation on investments

 (85,832 (1,453,349
  

 

 

  

 

 

 

Net loss on investments

 (43,271 (1,072,730
  

 

 

  

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$72,945  $(694,960
  

 

 

  

 

 

 

 

24


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

May 31, 2015

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
 Current
Rate
  Maturity
Date
  Principal/
Number
of Shares
  Cost  Fair Value 

Education Management II LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares Equity  0.00   6,692   $669,214   $301,140  

Education Management II LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares Equity  0.00   18,975    1,897,538    189,750  

24 Hour Holdings III LLC

 Leisure Goods/Activities/Movies Term Loan Loan  4.75  5/28/2021   $496,250    491,913    476,400  

Acosta Holdco Inc.

 Media Term Loan B1 Loan  4.25  9/27/2021   $1,990,000    1,975,220    1,992,806  

Aderant North America, Inc.

 Services: Business Term Loan (First Lien) Loan  5.25  12/20/2018   $3,260,898    3,260,898    3,260,898  

Aspen Dental Management, Inc.

 Healthcare & Pharmaceuticals Term Loan Initial Loan  5.50  4/27/2022   $500,000    497,525    504,375  

Advantage Sales & Marketing Inc.

 Services: Business Delayed Draw Term Loan Loan  4.25  7/25/2021   $2,490,000    2,486,539    2,485,344  

AECOM Technology Corporation

 Services: Business Term Loan B Loan  3.75  10/15/2021   $319,103    317,635    320,900  

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan Loan  5.50  2/24/2021   $992,500    992,500    967,687  

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  4.50  4/16/2021   $497,500    495,530    498,276  

Albertson’s LLC

 Retailers (Except Food and Drugs) Term Loan B-4 Loan  5.50  8/25/2021   $3,410,000    3,390,923    3,427,971  

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Incremental B-1 Term Loan Loan  4.25  6/30/2017   $1,524,604    1,524,604    1,526,830  

Alvogen Pharma US, Inc

 Healthcare & Pharmaceuticals Term Loan Loan  5.00  4/2/2022   $500,000    497,572    502,915  

American Tire Distributors Inc

 Automotive Term Loan B Loan  4.25  9/1/2021   $496,487    495,668    501,040  

Aramark Corporation

 Food Products LC-2 Facility Loan  3.74  7/26/2016   $79,187    79,177    78,593  

Aramark Corporation

 Food Products LC-3 Facility Loan  3.74  7/26/2016   $43,961    43,961    43,631  

Aramark Corporation

 Food Products U.S. Term F Loan Loan  3.25  2/24/2021   $3,174,472    3,174,472    3,170,504  

ARG IH Corp

 Food Services Term Loan Loan  4.75  11/15/2020   $483,163    482,308    484,975  

American Beacon Advisors, Inc.

 Financial Intermediaries Term Loan (First Lien) Loan  5.50  4/30/2022   $250,000    248,759    252,812  

Asurion, LLC (fka Asurion Corporation)

 Insurance Incremental Tranche B-1 Term Loan Loan  5.00  5/24/2019   $5,397,939    5,358,755    5,414,834  

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan Loan  5.25  6/24/2017   $3,913,710    3,905,683    3,913,710  

Avast Software

 Electronics/Electric Term Loan Loan  4.75  3/20/2020   $1,900,000    1,898,425    1,911,077  

AZ Chem US Inc.

 Chemicals/Plastics Term Loan Loan  5.25  6/12/2021   $460,274    458,212    460,274  

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) New Term Loan Loan  3.75  11/20/2019   $492,348    491,947    492,348  

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) Term Loan Loan  3.75  11/20/2019   $1,007,652    1,005,133    1,007,652  

Bayonne Energy Center

 Oil & Gas Term Loan B Loan  5.00  8/19/2021   $533,481    531,096    536,148  

Belmond Interfin Ltd.

 Lodging & Casinos Term Loan Loan  4.00  3/19/2021   $495,000    492,889    494,381  

Berry Plastics Corporation

 Chemicals/Plastics Term E Loan Loan  3.75  1/6/2021   $1,814,499    1,802,988    1,814,499  

Biomet, Inc.

 Healthcare & Pharmaceuticals Dollar Term B-2 Loan Loan  3.65  7/25/2017   $1,840,718    1,840,718    1,838,325  

BJ’s Wholesale Club, Inc.

 Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien) Loan  4.50  9/26/2019   $1,486,212    1,485,225    1,489,304  

Blue Coat Systems

 Technology Term Loan B Loan  4.50  5/19/2022   $1,000,000    997,500    1,001,250  

BMC Software

 Technology Term Loan Loan  5.00  9/10/2020   $1,994,950    1,933,227    1,948,407  

Bombardier Recreational Products Inc.

 Leisure Goods/Activities/Movies Term B Loan Loan  4.00  1/30/2019   $754,286    750,526    753,516  

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan  4.00  12/18/2020   $1,487,481    1,475,540    1,484,699  

Brock Holdings III, Inc.

 Industrial Equipment Term Loan (First Lien) Loan  6.00  3/16/2017   $1,933,169    1,945,346    1,921,087  

Burlington Coat Factory Warehouse Corporation

 Retailers (Except Food and Drugs) Term B-2 Loan Loan  4.25  8/13/2021   $1,861,667    1,853,261    1,865,800  

BWAY Holding Company

 Leisure Goods/Activities/Movies Term Loan B Loan  5.50  8/14/2020   $992,500    983,770    995,805  

Caesars Entertainment Corp.

 Lodging & Casinos Term B-7 Loan Loan  9.75  1/28/2018   $995,000    989,683    900,167  

Camp International Holding Company

 Aerospace and Defense 2013 Replacement Term Loan (First Lien) Loan  4.75  5/31/2019   $1,955,057    1,960,381    1,958,107  

Capital Automotive L.P.

 Conglomerate Tranche B-1 Term Loan Facility Loan  4.00  4/10/2019   $2,073,747    2,077,935    2,081,523  

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan Loan  4.25  5/20/2021   $496,250    494,094    497,804  

Celanese US Holdings LLC

 Chemicals/Plastics Dollar Term C-2 Commitment Loan  2.49  10/31/2018   $2,149,147    2,173,337    2,156,905  

Cengage Learning Acquisitions, Inc.

 Publishing Term Loan Loan  7.00  3/31/2020   $2,724,987    2,753,442    2,730,328  

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan Loan  3.00  12/31/2020   $2,649,005    2,640,702    2,632,078  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term F Loan Loan  3.25  12/31/2018   $1,097,819    1,077,865    1,099,653  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term G Loan Loan  3.75  12/31/2019   $1,027,707    1,000,275    1,029,568  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term H Loan Loan  4.00  1/27/2021   $1,890,955    1,840,450    1,894,377  

Cinedigm Digital Funding I, LLC

 Services: Business Term Loan Loan  3.75  2/28/2018   $490,397    487,081    490,397  

CITGO Petroleum Corporation

 Oil & Gas Term Loan B Loan  4.50  7/29/2021   $995,000    991,770    997,070  

ClubCorp Club Operations, Inc.

 Lodging & Casinos Term Loan B Loan  4.50  7/24/2020   $500,000    496,250    501,125  

Communications Sales & Leasing, Inc.

 Telecommunications Term Loan B (First Lien) Loan  5.00  10/24/2022   $2,000,000    1,987,560    1,990,500  

CommScope, Inc.

 Telecommunications Term Loan B Loan  4.00  5/27/2022   $500,000    498,750    500,625  

Concordia Healthcare Corp

 Healthcare & Pharmaceuticals Term Loan B Loan  4.75  4/21/2022   $250,000    248,764    251,875  

CPI International Acquisition, Inc.
(f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan Loan  4.25  11/17/2017   $3,586,275    3,586,275    3,568,344  

Crosby US Acquisition Corp.

 Industrial Equipment Initial Term Loan (First Lien) Loan  3.75  11/23/2020   $740,625    739,888    700,816  

Crown Castle Operating Company

 Telecommunications/Cellular Extended Incremental Tranche B-2 Term Loan Loan  3.00  1/31/2021   $2,429,443    2,427,500    2,424,536  

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan (First Lien) Loan  6.00  12/1/2021   $1,496,250    1,482,153    1,499,362  

Culligan International Company

 Conglomerate Dollar Loan (First Lien) Loan  6.25  12/19/2017   $777,637    738,020    764,029  

Culligan International Company

 Conglomerate Dollar Loan (Second Lien) Loan  9.50  6/19/2018   $783,162    742,154    744,333  

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan Loan  4.25  12/23/2020   $470,093    466,256    445,413  

Custom Sensors & Technologies, Inc.

 Industrial Equipment Term Loan Loan  4.50  9/30/2021   $497,500    496,476    497,500  

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

 Healthcare & Pharmaceuticals Tranche B Term Loan Loan  3.50  6/24/2021   $496,250    494,065    496,994  

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan Loan  7.25  3/19/2018   $3,231,044    3,210,653    3,191,432  

Dealertrack Technologies, Inc.

 Leisure Goods/Activities/Movies Term B Loan Loan  3.25  2/26/2021   $477,011    476,070    476,214  

Dell International LLC

 Retailers (Except Food and Drugs) Term B Loan Loan  4.50  4/29/2020   $2,926,941    2,915,287    2,928,170  

Delos Finance SARL

 Financial Intermediaries Term Loan Loan  3.50  3/6/2021   $500,000    497,909    500,000  

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term Loan B-3 Loan  4.75  7/30/2021   $1,000,000    995,563    999,310  

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  6.50  2/28/2020   $1,882,982    1,884,624    1,835,908  

Devix US, Inc.

 Chemicals/Plastics Term Loan Loan  4.25  5/2/2021   $250,000    247,779    249,688  

Devix US, Inc.

 Chemicals/Plastics Term Loan (Second Lien) Loan  8.00  5/2/2022   $496,250    494,151    497,024  

Diamond Resorts International

 Lodging & Casinos Term Loan Loan  5.50  5/9/2021   $926,971    922,892    926,971  

DJO Finance LLC

 Healthcare & Pharmaceuticals Term Loan Loan  4.25  6/8/2020   $500,000    497,921    500,750  

Dollar Tree Stores Inc.

 Retail Term Loan B (3950MM) Loan  4.25  3/9/2022   $1,000,000    995,086    1,009,030  

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan 2015 Incr Dollar Loan  4.25  3/11/2021   $2,977,500    2,971,293    2,959,814  

Drew Marine Group Inc.

 Chemicals/Plastics Term Loan (First Lien) Loan  4.50  11/19/2020   $1,472,161    1,477,822    1,469,408  

Education Management LLC

 Leisure Goods/Activities/Movies Term Loan A Loan  5.50  7/2/2020   $501,970    482,966    422,910  

Education Management LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  

 
 
 
 

8.50

(2.00%
Cash/
6.50%
PIK)


  
 
  
  

  7/2/2020   $850,514    820,457    634,696  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  4.50  8/1/2021   $497,500    495,276    498,122  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.75  8/1/2022   $500,000    497,728    498,440  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan B1A Loan  4.50  7/30/2021   $1,000,000    990,354    988,330  

EnergySolutions, LLC

 Oil & Gas Term Loan B Loan  6.75  5/29/2020   $937,857    921,782    941,374  

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan Loan  5.00  7/9/2019   $972,562    970,551    948,248  

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien) Loan  4.75  1/15/2021   $1,982,462    1,977,634    1,979,984  

Federal-Mogul Corporation

 Automotive Tranche C Term Loan Loan  4.75  4/15/2021   $2,977,500    2,964,818    2,966,811  

First Data Corporation

 Financial Intermediaries 2017 Second New Dollar Term Loan Loan  3.74  3/23/2018   $2,790,451    2,734,063    2,788,944  

First Data Corporation

 Financial Intermediaries 2018 Dollar Term Loan Loan  4.24  3/24/2021   $2,111,028    2,024,645    2,116,833  

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  5.50  7/1/2020   $1,488,750    1,479,155    1,455,253  

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 Nonferrous Metals/Minerals Loan Loan  3.75  6/28/2019   $1,977,443    1,977,366    1,790,199  

Four Seasons Holdings Inc.

 Lodging & Casinos Term Loan (First Lien) Loan  3.50  6/27/2020   $489,865    489,865    490,271  

Garda World Security Corporation

 Services: Business Term B Delayed Draw Loan Loan  4.00  11/6/2020   $200,648    199,825    199,896  

Garda World Security Corporation

 Services: Business Term B Loan Loan  4.00  11/6/2020   $784,352    781,392    781,411  

Gardner Denver, Inc.

 Oil & Gas Initial Dollar Term Loan Loan  4.25  7/30/2020   $2,469,943    2,461,740    2,412,690  

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  4.25  7/3/2021   $497,500    492,525    494,888  

Generac Power Systems, Inc.

 Industrial Equipment Term Loan B Loan  3.25  5/29/2020   $693,858    683,135    690,680  

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan  3.25  3/4/2019   $4,720,142    4,706,492    4,667,041  

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien) Loan  5.00  5/26/2020   $2,747,966    2,740,001    2,706,746  

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien) Loan  4.75  4/30/2019   $3,333,333    3,298,766    3,355,000  

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan Loan  3.75  1/4/2021   $3,395,892    3,381,806    3,381,052  

GTCR Valor Companies, Inc.

 Services: Business Term Loan (First Lien) Loan  6.00  6/1/2021   $1,989,995    1,950,196    1,987,508  

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing Tranche B-4 Term Loan Loan  6.00  8/2/2019   $484,375    482,452    485,184  

HCA Inc.

 Healthcare & Pharmaceuticals Tranche B-4 Term Loan Loan  2.99  5/1/2018   $5,648,670    5,415,004    5,648,105  

Headwaters Incorporated

 Building & Development Term Loan Loan  4.50  3/24/2022   $250,000    248,764    250,625  

Hertz Corporation, The

 Automotive Tranche B-1 Term Loan Loan  4.00  3/12/2018   $2,932,500    2,964,832    2,933,556  

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan Loan  5.25  5/8/2020   $1,985,000    1,968,036    1,994,925  

Huntsman International LLC

 Chemicals/Plastics Extended Term B Loan Loan  2.69  4/19/2017   $3,840,541    3,813,492    3,840,541  

Husky Injection Molding Systems Ltd.

 Services: Business Term Loan B Loan  4.25  6/30/2021   $491,797    489,720    492,761  

Infor (US), Inc. (fka Lawson Software Inc.)

 Services: Business Tranche B-5 Term Loan Loan  3.75  6/3/2020   $2,205,351    2,189,132    2,195,361  

Insight Global

 Services: Business Term Loan Loan  6.00  10/29/2021   $1,994,898    1,986,758    1,998,229  

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014 Loan  4.00  3/5/2021   $962,775    962,775    872,188  

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14 Loan  4.50  6/19/2021   $496,364    495,123    492,641  

J.Jill Group, Inc.

 Retail Term Loan (First Lien) Loan  6.00  5/9/2022   $1,000,000    995,018    1,001,250  

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Dollar Term D-1 Loan Loan  4.00  5/4/2018   $2,471,356    2,449,511    2,486,802  

Koosharem, LLC

 Services: Business Term Loan Loan  7.50  5/15/2020   $2,987,513    2,962,552    2,970,095  

La Quinta Holdings, Inc.

 Lodging & Casinos Term Loan (First Lien) Loan  4.00  4/14/2021   $434,717    433,214    435,586  

Level 3 Financing, Inc.

 Telecommunications Term Loan B2 Loan  4.50  1/31/2022   $500,000    496,648    499,688  

Mauser Holdings, Inc.

 Containers/Glass Products Term Loan Loan  4.50  7/31/2021   $497,500    495,281    497,813  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term B Loan Loan  3.75  1/28/2020   $490,000    490,000    490,186  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B-2 Loan  4.00  1/28/2020   $1,488,750    1,482,222    1,493,469  

Microsemi Corporation

 Electronics/Electric Incremental Term Loan Loan  3.50  2/19/2020   $2,122,318    2,118,346    2,124,313  

Midas Intermediate Holdco II, LLC

 Automotive Delayed Draw Term Loan Loan  4.75  8/18/2021   $25,190    25,190    25,324  

Midas Intermediate Holdco II, LLC

 Automotive Term Loan B Loan  4.75  8/18/2021   $223,560    222,539    224,747  

Millenium Laboratories, LLC

 Drugs Term Loan Loan  5.25  4/16/2021   $1,488,750    1,475,773    1,001,929  

MPH Acquisition Holdings LLC

 Healthcare & Pharmaceuticals Term Loan Loan  3.75  3/31/2021   $431,818    430,910    430,739  

MSC Software Corp.

 Services: Business Term Loan Loan  5.00  5/29/2020   $992,500    984,127    985,056  

National CineMedia, LLC

 Leisure Goods/Activities/Movies Term Loan (2013) Loan  2.95  11/26/2019   $1,086,207    1,060,272    1,072,238  

National Veterinary Associates, Inc

 Healthcare & Pharmaceuticals Term Loan B Loan  4.75  8/14/2021   $995,006    991,489    995,832  

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien) Loan  6.75  3/11/2022   $250,000    249,731    243,125  

Newsday, LLC

 Publishing Term Loan Loan  3.69  10/12/2016   $2,215,385    2,214,480    2,209,846  

Nortek, Inc.

 Electronics/Electric Term B Loan Loan  3.75  10/30/2020   $992,500    980,651    988,778  

Novelis, Inc.

 Conglomerate Initial Term Loan Loan  3.75  3/10/2017   $4,795,033    4,803,880    4,790,142  

Novelis, Inc.

 Conglomerate Term Loan B Loan  3.75  3/10/2017   $4,795,033    4,771,058    4,790,142  

NPC International, Inc.

 Food Services Term Loan (2013) Loan  4.00  12/28/2018   $485,000    485,000    480,756  

NRG Energy, Inc.

 Utilities Term Loan (2013) Loan  2.75  7/2/2018   $3,851,400    3,833,925    3,825,095  

NuSil Technology LLC.

 Chemicals/Plastics Term Loan Loan  5.25  4/7/2017   $795,751    795,751    790,284  

Ollie’s Bargain Outlet, Inc

 Retailers (Except Food and Drugs) Term Loan Loan  4.75  9/30/2019   $974,527    970,576    969,654  

On Assignment, Inc.

 Services: Business Initial Term B Loan Loan  3.50  5/15/2020   $1,311,364    1,303,800    1,310,957  

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013) Loan  5.00  6/7/2019   $3,996,811    3,982,808    3,993,054  

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Delayed Draw Term Loan Loan  4.75  10/1/2021   $48,537    48,182    48,294  

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B Loan  4.75  10/1/2021   $448,963    445,914    446,719  

OpenLink International LLC

 Services: Business Term B Loan Loan  6.25  10/28/2017   $2,967,500    2,965,974    2,952,663  

Orbitz Worldwide, Inc.

 Services: Business Term Loan (First Lien) Loan  4.50  4/15/2021   $1,408,613    1,406,579    1,409,500  

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing Loan  4.25  6/24/2019   $1,444,113    1,437,299    1,427,867  

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien) Loan  5.00  10/30/2020   $987,500    983,132    966,516  

Par Pharmaceutical Companies, Inc.

 Healthcare & Pharmaceuticals Term Loan B3 Loan  4.25  9/28/2019   $498,750    496,360    499,583  

Penn Products Terminal, LLC

 Chemicals/Plastics Term Loan B Loan  4.75  4/13/2022   $250,000    248,773    251,875  

PetCo Animal Supplies Stores, Inc.

 Retailers (Except Food and Drugs) New Loans Loan  4.00  11/24/2017   $1,465,561    1,464,910    1,467,584  

Petsmart, Inc. (Argos Merger Sub, Inc.)

 Retail Term Loan B1 Loan  4.25  3/11/2022   $1,000,000    995,088    1,002,140  

PGX Holdings, Inc.

 Financial Intermediaries Term Loan Loan  6.25  9/29/2020   $987,500    978,766    990,788  

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

 Conglomerate 2013 Term Loan Loan  4.00  12/5/2018   $1,935,450    1,914,850    1,937,521  

Phillips-Medisize Corporation

 Healthcare & Pharmaceuticals Term Loan Loan  4.75  6/16/2021   $496,250    494,073    495,942  

Physio-Control International, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  5.50  5/19/2022   $500,000    497,500    501,875  

Pinnacle Foods Finance LLC

 Food Products New Term Loan G Loan  3.00  4/29/2020   $2,581,332    2,576,895    2,572,813  

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan Loan  4.75  3/31/2021   $2,485,000    2,477,540    2,478,788  

Polymer Group, Inc.

 Chemicals/Plastics Initial Loan Loan  5.25  12/19/2019   $493,750    491,694    495,394  

Post Holdings, Inc.

 Consumer Goods: Non-Durable Term Loan Series A Loan  3.75  6/2/2021   $1,000,000    994,500    995,180  

PrePaid Legal Services, Inc.

 Services: Business Term Loan B Loan  6.50  7/1/2019   $750,000    746,250    750,623  

Presidio, Inc.

 Services: Business Term Loan Loan  5.25  2/2/2022   $1,916,667    1,861,770    1,920,270  

Prestige Brands, Inc.

 Consumer Goods: Durable Term B-3 Loan Loan  3.50  9/3/2021   $2,112,374    2,104,893    2,114,127  

Quintiles Transnational Corp.

 Services: Business Term Loan B Loan  3.25  5/6/2022   $1,000,000    997,510    1,002,190  

Ranpak Holdings, Inc.

 Services: Business Term Loan Loan  4.25  10/1/2021   $995,000    992,728    995,000  

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien) Loan  8.25  9/30/2022   $500,000    497,726    499,585  

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien) Loan  4.50  12/3/2020   $493,750    490,848    493,133  

Regal Cinemas Corporation

 Services: Consumer Term Loan Loan  3.75  4/1/2022   $500,000    498,780    501,640  

Research Now Group, Inc

 Media Term Loan B Loan  5.50  3/18/2021   $500,000    497,544    501,875  

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan Loan  4.00  8/21/2020   $1,642,630    1,644,003    1,639,690  

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan Loan  4.00  12/1/2018   $1,910,551    1,910,551    1,916,531  

Riverbed Technology, Inc.

 Technology Term Loan B Loan  6.00  2/25/2022   $1,000,000    995,138    1,009,380  

Rocket Software, Inc.

 Services: Business Term Loan (First Lien) Loan  5.75  2/8/2018   $1,916,674    1,900,419    1,916,674  

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric Tranche B-3 Term Loan Loan  3.75  7/2/2021   $1,488,750    1,482,202    1,481,306  

RPI Finance Trust

 Financial Intermediaries Term B-4 Term Loan Loan  3.50  11/9/2020   $5,194,247    5,194,247    5,194,247  

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien) Loan  5.00  3/27/2021   $990,000    985,714    891,000  

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2 Loan  6.00  10/1/2021   $997,500    988,352    996,440  

Seadrill Operating LP

 Oil & Gas Term Loan B Loan  4.00  2/21/2021   $994,962    918,242    811,929  

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

 Industrial Equipment Term Loan Loan  3.00  10/11/2021   $1,264,400    1,264,400    1,266,878  

Sensus USA Inc. (fka Sensus Metering Systems)

 Utilities Term Loan (First Lien) Loan  4.50  5/9/2017   $1,920,081    1,916,275    1,912,880  

ServiceMaster Company, The

 Conglomerate Tranche B Term Loan Loan  4.25  7/1/2021   $1,990,000    1,972,330    1,994,657  

Shearers Foods LLC

 Food Services Term Loan (First Lien) Loan  4.50  6/30/2021   $995,000    992,823    994,383  

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  5.50  12/10/2020   $224,437    223,922    224,999  

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan Loan  5.50  12/10/2020   $1,271,813    1,268,891    1,274,992  

Sophia, L.P.

 Electronics/Electric Term B Loan Loan  4.00  7/19/2018   $883,715    875,972    884,599  

SourceHOV LLC

 Services: Business Term Loan B (First Lien) Loan  7.75  10/31/2019   $1,987,500    1,932,692    1,828,500  

SRAM, LLC

 Industrial Equipment Term Loan (First Lien) Loan  4.00  4/10/2020   $2,935,089    2,926,129    2,930,187  

Staples, Inc.

 Retail Term Loan B Loan  3.50  4/23/2021   $1,000,000    995,000    1,000,940  

Steak ‘n Shake Operations, Inc.

 Food Services Term Loan Loan  4.75  3/19/2021   $990,000    981,539    985,050  

SunGard Data Systems Inc. (Solar Capital Corp.)

 Conglomerate Tranche C Term Loan Loan  3.90  2/28/2017   $285,352    283,389    285,472  

SunGard Data Systems Inc. (Solar Capital Corp.)

 Conglomerate Tranche E Term Loan Loan  4.00  3/9/2020   $3,707,953    3,622,675    3,714,924  

SuperMedia Inc. (fka Idearc Inc.)

 Publishing Loan Loan  11.60  12/30/2016   $235,379    230,025    158,528  

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan Loan  4.00  4/23/2019   $479,913    476,313    458,917  

TGI Friday’s Inc

 Food Services Term Loan B Loan  5.25  7/15/2020   $1,761,386    1,756,571    1,761,386  

Townsquare Media, Inc.

 Media Term Loan B Loan  4.25  4/1/2022   $1,000,000    995,060    1,005,420  

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B Loan  5.50  10/2/2021   $498,750    495,598    504,516  

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan Loan  3.75  2/28/2020   $4,310,366    4,318,132    4,297,435  

TransDigm, Inc.

 Aerospace and Defense Tranche E Term Loan Loan  3.50  5/13/2022   $2,000,000    1,990,600    1,985,000  

TransFirst Holdings, Inc.

 Financial Intermediaries Term Loan Loan  5.50  11/12/2021   $498,750    494,148    498,022  

Trans Union LLC

 Financial Intermediaries Term Loan Loan  4.00  4/9/2021   $495,000    493,963    493,322  

Travel Leaders Group, LLC

 Hotel, Gaming and Leisure Term Loan B Loan  7.00  12/7/2020   $1,000,000    995,055    1,010,000  

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

 Containers/Glass Products Term Loan Loan  4.00  5/3/2018   $1,836,625    1,830,188    1,827,442  

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

 Healthcare & Pharmaceuticals New Tranche B Term Loan Loan  4.50  6/6/2019   $486,325    479,056    486,529  

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B Loan  5.25  7/10/2020   $956,192    958,419    953,801  

U.S. Security Associates Holdings, Inc.

 Services: Business Delayed Draw Loan Loan  6.25  7/28/2017   $158,110    157,308    157,814  

U.S. Security Associates Holdings, Inc.

 Services: Business Term B Loan Loan  6.25  7/28/2017   $928,641    924,314    926,905  

United Surgical Partners International, Inc.

 Healthcare & Pharmaceuticals New Tranche B Term Loan Loan  4.75  4/3/2019   $2,425,561    2,403,697    2,425,561  

Univar Inc.

 Chemicals/Plastics Term B Loan Loan  5.00  6/30/2017   $3,834,969    3,834,775    3,830,175  

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan Loan  4.00  3/1/2020   $2,939,724    2,924,949    2,934,667  

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B Loan  3.50  2/13/2019   $2,545,588    2,537,897    2,543,272  

Verint Systems Inc.

 Services: Business Term Loan Loan  3.50  9/6/2019   $1,014,058    1,010,683    1,015,325  

Vertafore, Inc.

 Services: Business Term Loan (2013) Loan  4.25  10/3/2019   $2,484,603    2,484,603    2,490,815  

Vouvray US Finance

 Industrial Equipment Term Loan Loan  5.00  6/28/2021   $496,250    494,080    498,319  

Washington Inventory Service

 Services: Business U.S. Term Loan (First Lien) Loan  5.75  12/20/2018   $1,832,875    1,850,149    1,800,800  

Waste Industries

 Environmental Term Loan B Loan  4.25  2/27/2020   $250,000    249,405    251,145  

Wendy’s International, Inc

 Food Services Term B Loan Loan  3.25  5/15/2019   $671,921    666,709    671,753  

West Corporation

 Telecommunications Term B-10 Loan Loan  3.25  6/30/2018   $2,571,560    2,603,429    2,565,490  
       

 

 

  

 

 

 
$307,289,860  $304,682,956  
       

 

 

  

 

 

 

 

25


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2015

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
 Current
Rate
  Maturity
Date
  Principal/
Number
of Shares
  Cost  Fair Value 

Education Management II LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares Equity  0.00   6,692   $669,214   $437,188  

Education Management II LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares Equity  0.00   18,975    1,897,538    180,263  

24 Hour Holdings III LLC

 Leisure Goods/Activities/Movies Term Loan Loan  4.75  5/28/2021   $497,500    493,004    492,276  

Acosta Holdco Inc.

 Media Term Loan B Loan  5.00  9/27/2021   $1,995,000    1,981,328    2,004,416  

Aderant North America, Inc.

 Services: Business Term Loan (First Lien) Loan  5.25  12/20/2018   $3,260,898    3,260,898    3,240,517  

Advantage Sales & Marketing Inc.

 Services: Business Delayed Draw Term Loan Loan  4.25  7/25/2021   $1,995,000    1,993,940    1,984,287  

AECOM Technology Corporation

 Services: Business Term Loan B Loan  3.75  10/15/2021   $319,903    318,380    321,304  

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan Loan  5.50  2/24/2021   $995,000    995,000    997,488  

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  4.50  4/16/2021   $498,750    496,691    500,411  

Albertson’s LLC

 Retailers (Except Food and Drugs) Term Loan B-4 Loan  5.50  8/25/2021   $3,410,000    3,389,632    3,437,723  

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Incremental B-1 Term Loan Loan  4.25  6/30/2017   $1,529,610    1,529,610    1,529,610  

American Tire Distributors Inc

 Automotive Term Loan Loan  5.75  6/1/2018   $496,487    496,486    497,108  

Aramark Corporation

 Food Products LC-2 Facility Loan  3.74  7/26/2016   $79,187    79,178    78,395  

Aramark Corporation

 Food Products LC-3 Facility Loan  3.74  7/26/2016   $43,961    43,961    43,521  

Aramark Corporation

 Food Products U.S. Term F Loan Loan  3.25  2/24/2021   $3,182,489    3,182,489    3,168,581  

ARG IH Corp

 Food Services Term Loan Loan  4.75  11/15/2020   $495,000    494,038    495,312  

Asurion, LLC (fka Asurion Corporation)

 Insurance Incremental Tranche B-1 Term Loan Loan  5.00  5/24/2019   $5,412,086    5,370,590    5,424,642  

Auction.Com, LLC

 Services: Business Term Loan A-4 Loan  4.40  2/28/2017   $914,567    914,567    905,422  

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan Loan  5.25  6/24/2017   $4,319,115    4,309,242    4,297,520  

Avast Software

 Electronics/Electric Term Loan Loan  4.75  3/20/2020   $1,925,000    1,923,275    1,937,031  

AZ Chem US Inc.

 Chemicals/Plastics Term Loan Loan  5.25  6/12/2021   $467,123    464,958    466,614  

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) New Term Loan Loan  3.75  11/20/2019   $493,623    493,111    492,236  

Bayonne Energy Center

 Oil & Gas Term Loan B Loan  5.00  8/19/2021   $969,671    965,093    964,416  

Belmond Hotels

 Lodging & Casinos Term Loan Loan  4.00  3/19/2021   $496,250    494,055    495,009  

Berry Plastics Corporation

 Chemicals/Plastics Term E Loan Loan  3.75  1/6/2021   $1,814,499    1,802,403    1,812,648  

Big Heart Pet Brands (fka Del Monte Corporation)

 Food/Drug Retailers Initial Term Loan Loan  3.50  3/9/2020   $2,977,500    2,996,769    2,971,307  

Biomet, Inc.

 Healthcare & Pharmaceuticals Dollar Term B-2 Loan Loan  3.65  7/25/2017   $1,840,718    1,840,718    1,838,601  

BJ’s Wholesale Club, Inc.

 Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien) Loan  4.50  9/26/2019   $1,489,975    1,488,922    1,483,374  

Bombardier Recreational Products Inc.

 Leisure Goods/Activities/Movies Term B Loan Loan  4.00  1/30/2019   $754,286    750,287    747,120  

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan  4.00  12/18/2020   $1,491,237    1,478,800    1,478,935  

Brock Holdings III, Inc.

 Industrial Equipment Term Loan (First Lien) Loan  6.00  3/16/2017   $1,938,503    1,952,391    1,904,580  

Burlington Coat Factory Warehouse Corporation

 Retailers (Except Food and Drugs) Term B-2 Loan Loan  4.25  8/13/2021   $1,945,000    1,935,814    1,942,219  

BWAY

 Leisure Goods/Activities/Movies Term Loan B Loan  5.50  8/14/2020   $995,000    985,881    998,423  

Caesars Entertainment Corp.

 Lodging & Casinos Term B-7 Loan Loan  9.75  1/28/2018   $995,000    989,028    917,141  

Camp International Holding Company

 Aerospace and Defense 2013 Replacement Term Loan (First Lien) Loan  4.75  5/31/2019   $1,960,046    1,965,495    1,969,846  

Capital Automotive L.P.

 Conglomerate Tranche B-1 Term Loan Facility Loan  4.00  4/10/2019   $2,079,313    2,083,783    2,084,511  

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan Loan  4.25  5/20/2021   $497,500    495,170    498,401  

Celanese US Holdings LLC

 Chemicals/Plastics Dollar Term C-2 Commitment Loan  2.49  10/31/2018   $2,154,560    2,180,598    2,157,533  

Cengage Learning

 Publishing Term Loan Loan  7.00  3/31/2020   $2,731,869    2,761,735    2,733,235  

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan Loan  3.00  12/31/2020   $2,655,745    2,646,932    2,646,344  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals 2017 Term E Loan Loan  3.49  1/25/2017   $1,097,818    1,074,945    1,097,193  

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals 2021 Term D Loan Loan  4.25  1/27/2021   $2,926,052    2,844,886    2,935,210  

Cinedigm Digital Funding I, LLC

 Services: Business Term Loan Loan  3.75  2/28/2018   $562,001    557,872    561,298  

CITGO Petroleum

 Oil & Gas Term Loan B Loan  4.50  7/29/2021   $997,500    994,095    979,106  

ClubCorp Club Operations, Inc.

 Lodging & Casinos Term Loan B Loan  4.50  7/24/2020   $500,000    496,250    500,315  

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan Loan  4.25  11/17/2017   $3,595,331    3,595,331    3,570,631  

Crosby US Acquisition Corp.

 Industrial Equipment Initial Term Loan (First Lien) Loan  3.75  11/23/2020   $742,500    741,718    681,244  

Crown Castle Operating Company

 Telecommunications/Cellular Extended Incremental Tranche B-2 Term Loan Loan  3.00  1/31/2021   $2,435,594    2,433,546    2,430,723  

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan (First Lien) Loan  6.00  12/1/2021   $1,500,000    1,485,423    1,505,625  

Culligan International Company

 Conglomerate Dollar Loan (First Lien) Loan  6.25  12/19/2017   $779,642    736,275    765,998  

Culligan International Company

 Conglomerate Dollar Loan (Second Lien) Loan  9.50  6/19/2018   $783,162    739,367    727,033  

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan Loan  4.25  12/23/2020   $470,093    466,100    466,863  

Custom Sensors

 Industrial Equipment Term Loan Loan  4.50  9/30/2021   $498,750    497,651    498,750  

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

 Healthcare & Pharmaceuticals Tranche B Term Loan Loan  3.50  6/24/2021   $497,500    495,228    498,062  

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan Loan  7.25  3/19/2018   $3,460,027    3,436,485    3,413,835  

Dealertrack Technologies, Inc.

 Leisure Goods/Activities/Movies Term B Loan Loan  3.25  2/26/2021   $477,011    475,991    474,230  

Dell International LLC

 Retailers (Except Food and Drugs) Term B Loan Loan  4.50  4/29/2020   $2,969,962    2,957,576    2,980,684  

Delos Finance SARL

 Financial Intermediaries Term Loan Loan  3.50  3/6/2021   $500,000    497,835    499,790  

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term Loan B-3 Loan  4.75  7/30/2021   $1,000,000    995,314    995,630  

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  6.50  2/28/2020   $1,882,983    1,884,624    1,835,908  

Devix US, Inc.

 Chemicals/Plastics Term Loan Loan  4.25  5/2/2021   $250,000    247,710    250,938  

Devix US, Inc.

 Chemicals/Plastics Term Loan (Second Lien) Loan  8.00  5/2/2022   $497,500    495,324    497,500  

Diamond Resorts International

 Lodging & Casinos Term Loan Loan  5.50  5/9/2021   $995,000    990,370    999,975  

Dollar Tree

 Retail Term Loan B (3950MM) Loan  4.25  3/9/2022   $1,000,000    995,000    1,007,500  

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan Loan  4.25  3/11/2021   $2,985,000    2,978,605    2,962,075  

Drew Marine Group Inc.

 Chemicals/Plastics Term Loan (First Lien) Loan  4.50  11/19/2020   $1,489,975    1,495,721    1,473,213  

Education Management LLC

 Leisure Goods/Activities/Movies Term Loan A Loan  5.50  7/2/2020   $501,970    482,120    457,295  

Education Management LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  
 
 
 
 
8.50%
(2.00%
Cash/
6.50%
PIK)
  
  
 
  
  
  7/2/2020   $836,617    805,283    672,882  

EIG Investors Corp.

 Services: Business Term Loan Loan  5.00  11/8/2019   $987,500    983,552    989,969  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  4.50  8/1/2021   $498,750    496,403    496,102  

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.75  8/1/2022   $500,000    497,553    484,845  

EnergySolutions, LLC

 Oil & Gas Term Loan B Loan  6.75  5/29/2020   $937,857    921,126    942,546  

Enviromental Resources Management

 Services: Business Term Loan Loan  5.00  5/14/2021   $1,000,000    990,000    985,000  

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan Loan  5.00  7/9/2019   $975,056    972,887    955,555  

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien) Loan  4.75  1/15/2021   $1,987,481    1,982,274    1,972,575  

Federal-Mogul Corporation

 Automotive Tranche C Term Loan Loan  4.75  4/15/2021   $2,985,000    2,971,883    2,975,687  

First Data Corporation

 Financial Intermediaries 2017 Second New Dollar Term Loan Loan  3.74  3/23/2018   $2,790,451    2,729,399    2,785,568  

First Data Corporation

 Financial Intermediaries 2018 Dollar Term Loan Loan  4.24  3/24/2021   $2,111,028    2,021,476    2,115,777  

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  5.50  7/1/2020   $1,492,500    1,482,322    1,421,606  

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 Nonferrous Metals/Minerals Loan Loan  3.75  6/28/2019   $1,982,462    1,982,212    1,835,423  

Four Seasons Holdings Inc.

 Lodging & Casinos Term Loan (First Lien) Loan  3.50  6/27/2020   $493,750    493,750    491,281  

Garda World Security Corporation

 Services: Business Term B Delayed Draw Loan Loan  4.00  11/6/2020   $201,157    200,308    199,146  

Garda World Security Corporation

 Services: Business Term B Loan Loan  4.00  11/6/2020   $786,343    783,060    778,479  

Gardner Denver, Inc.

 Oil & Gas Initial Dollar Term Loan Loan  4.25  7/30/2020   $2,476,212    2,467,608    2,377,164  

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  4.25  7/3/2021   $498,750    493,763    494,885  

Generac Power Systems, Inc.

 Industrial Equipment Term Loan B Loan  3.25  5/29/2020   $802,956    789,932    797,182  

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan  3.25  3/4/2019   $4,724,136    4,709,712    4,649,353  

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien) Loan  5.00  5/26/2020   $2,755,515    2,747,025    2,719,914  

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien) Loan  4.75  4/30/2019   $3,333,333    3,296,753    3,347,933  

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan Loan  3.75  1/4/2021   $3,395,892    3,381,240    3,353,443  

GTCR Valor Companies, Inc.

 Services: Business Term Loan (First Lien) Loan  6.00  6/1/2021   $1,995,000    1,981,582    1,965,075  

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing Tranche B-4 Term Loan Loan  6.00  8/2/2019   $487,500    485,460    488,963  

HCA Inc.

 Healthcare & Pharmaceuticals Tranche B-4 Term Loan Loan  2.99  5/1/2018   $5,663,006    5,409,534    5,658,872  

Hertz Corporation, The

 Automotive Tranche B-1 Term Loan Loan  4.00  3/12/2018   $2,940,000    2,975,234    2,927,152  

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan Loan  5.25  5/8/2020   $1,990,000    1,972,040    1,999,950  

Huntsman International LLC

 Chemicals/Plastics Extended Term B Loan Loan  2.69  4/19/2017   $3,880,270    3,866,113    3,872,199  

Husky Injection

 Services: Business Term Loan B Loan  4.25  6/30/2021   $498,099    495,886    495,818  

Ikaria, Inc.

 Healthcare & Pharmaceuticals Initial Term Loan (First Lien) Loan  5.00  2/12/2021   $435,702    433,809    434,251  

Infor (US), Inc. (fka Lawson Software Inc.)

 Services: Business Tranche B-5 Term Loan Loan  3.75  6/3/2020   $2,211,036    2,194,068    2,190,650  

Insight Global

 Services: Business Term Loan Loan  6.00  10/29/2021   $2,000,000    1,990,539    1,993,760  

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014 Loan  4.00  3/5/2021   $965,206    965,206    906,493  

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14 Loan  4.50  6/19/2021   $497,576    496,332    492,913  

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Dollar Term D-1 Loan Loan  4.00  5/4/2018   $2,477,613    2,453,687    2,477,167  

Koosharem, LLC

 Services: Business Term Loan Loan  7.50  5/15/2020   $2,995,000    2,968,450    2,961,306  

La Quinta Holdings, Inc.

 Lodging & Casinos Term Loan (First Lien) Loan  4.00  4/14/2021   $451,283    449,626    450,719  

Level 3 Financing, Inc.

 Telecommunications Term Loan B Loan  4.50  1/31/2022   $500,000    496,541    502,085  

Mauser Holdings, Inc.

 Containers/Glass Products Term Loan Loan  4.50  7/31/2021   $498,750    496,409    491,269  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term B Loan Loan  3.75  1/28/2020   $491,250    491,250    488,258  

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B-2 Loan  4.00  1/28/2020   $1,492,500    1,485,638    1,488,769  

Microsemi Corporation

 Electronics/Electric Incremental Term Loan Loan  3.50  2/19/2020   $2,393,981    2,389,500    2,381,509  

Microsemi Corporation

 Electronics/Electric Term Loan Loan  3.75  2/19/2020   $172,170    172,170    171,309  

Midas Intermediate Holdco II, LLC

 Automotive Delayed Draw Term Loan Loan  4.75  8/18/2021   $25,253    25,253    25,364  

Midas Intermediate Holdco II, LLC

 Automotive Term Loan B Loan  4.75  8/18/2021   $224,122    223,063    225,103  

Millenium Laboratories, LLC

 Drugs Term Loan Loan  5.25  4/16/2021   $1,492,500    1,479,041    1,489,396  

Mitel US Holdings, Inc.

 Telecommunications Term Loan Loan  5.25  1/31/2020   $196,558    195,710    196,411  

MPH Acquisition Holdings LLC

 Healthcare & Pharmaceuticals Term Loan Loan  3.75  3/31/2021   $445,455    444,453    442,033  

MSC Software Corp.

 Services: Business Term Loan Loan  5.00  5/29/2020   $995,000    986,186    996,244  

National CineMedia, LLC

 Leisure Goods/Activities/Movies Term Loan (2013) Loan  2.95  11/26/2019   $1,086,207    1,058,933    1,067,198  

National Veterinary Associates, Inc

 Healthcare & Pharmaceuticals Term Loan B Loan  4.75  8/14/2021   $997,500    992,907    996,253  

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien) Loan  6.75  3/11/2022   $250,000    249,730    240,418  

Newsday, LLC

 Publishing Term Loan Loan  3.69  10/12/2016   $2,215,385    2,214,305    2,201,538  

Nortek, Inc.

 Electronics/Electric Term B Loan Loan  3.75  10/30/2020   $995,000    992,803    986,921  

Novelis, Inc.

 Conglomerate Initial Term Loan Loan  3.75  3/10/2017   $4,807,530    4,817,740    4,799,502  

NPC International, Inc.

 Food Services Term Loan (2013) Loan  4.00  12/28/2018   $486,250    486,250    480,780  

NRG Energy, Inc.

 Utilities Term Loan (2013) Loan  2.75  7/2/2018   $3,861,225    3,842,164    3,850,761  

NuSil Technology LLC.

 Chemicals/Plastics Term Loan Loan  5.25  4/7/2017   $797,986    797,986    791,004  

Ollie’s Bargain Outlet, Inc

 Retailers (Except Food and Drugs) Term Loan Loan  4.75  9/30/2019   $977,052    972,882    962,396  

On Assignment, Inc.

 Services: Business Initial Term B Loan Loan  3.50  5/15/2020   $1,311,364    1,303,451    1,301,528  

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013) Loan  5.00  6/7/2019   $4,074,401    4,059,378    4,078,842  

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Delayed Draw Term Loan Loan  4.75  10/1/2021   $—      —      —    

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B Loan  4.75  10/1/2021   $498,750    495,208    496,466  

OpenLink International LLC

 Services: Business Term B Loan Loan  6.25  10/28/2017   $970,000    970,000    957,875  

Orbitz Worldwide, Inc.

 Services: Business Term Loan (First Lien) Loan  4.50  4/15/2021   $1,494,994    1,492,711    1,494,755  

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing Loan  4.25  6/24/2019   $1,447,901    1,440,712    1,406,274  

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien) Loan  5.00  10/30/2020   $990,000    985,444    947,925  

Par Pharmaceutical

 Healthcare & Pharmaceuticals Term Loan B3 Loan  4.25  9/28/2019   $500,000    497,502    499,065  

PetCo Animal Supplies Stores, Inc.

 Retailers (Except Food and Drugs) New Loans Loan  4.00  11/24/2017   $1,469,388    1,468,520    1,467,066  

PetSmart

 Retail Term Loan B Loan  5.00  3/11/2022   $1,000,000    995,000    1,007,050  

PGX Holdings, Inc.

 Financial Intermediaries Term Loan Loan  6.25  9/29/2020   $993,750    984,482    993,750  

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

 Conglomerate 2013 Term Loan Loan  4.00  12/5/2018   $1,940,400    1,918,409    1,935,898  

Phillips-Medisize Corporation

 Healthcare & Pharmaceuticals Term Loan Loan  4.75  6/16/2021   $497,500    495,245    495,948  

Pinnacle Foods Finance LLC

 Food Products New Term Loan G Loan  3.00  4/29/2020   $2,581,332    2,576,466    2,565,560  

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan Loan  4.75  3/31/2021   $1,488,750    1,482,052    1,488,750  

Polymer Group, Inc.

 Chemicals/Plastics Initial Loan Loan  5.25  12/19/2019   $495,000    492,860    495,619  

Presidio

 Services: Business Term Loan B Loan  6.25  2/2/2022   $2,000,000    1,940,655    1,973,760  

Prestige Brands, Inc.

 Drugs Term B-1 Loan Loan  4.13  1/31/2019   $344,697    341,112    344,697  

Prestige Brands, Inc.

 Leisure Goods/Activities/Movies Term Loan Loan  4.50  9/3/2021   $1,861,111    1,858,280    1,860,534  

QoL Meds, LLC

 Healthcare & Pharmaceuticals Term Loan B Loan  5.50  7/15/2020   $1,995,000    1,985,909    1,990,013  

Quintiles Transnational Corp.

 Conglomerate Term B-3 Loan Loan  3.75  6/8/2018   $3,627,678    3,600,425    3,628,802  

Ranpak Holdings, Inc.

 Services: Business Term Loan Loan  4.75  10/1/2021   $997,500    995,145    996,882  

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien) Loan  8.25  9/30/2022   $500,000    497,672    496,250  

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien) Loan  4.50  12/3/2020   $495,000    491,974    494,381  

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan Loan  4.00  8/21/2020   $1,646,799    1,648,172    1,642,172  

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan Loan  4.00  12/1/2018   $1,960,200    1,960,200    1,965,767  

Riverbed Technology

 Technology Term Loan B Loan  6.00  2/25/2022   $1,000,000    995,000    1,007,500  

Rocket Software, Inc.

 Services: Business Term Loan (First Lien) Loan  5.75  2/8/2018   $1,916,674    1,898,764    1,906,285  

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric Tranche B-3 Term Loan Loan  3.75  7/2/2021   $1,492,500    1,485,607    1,479,441  

RPI Finance Trust

 Drugs Term B-2 Term Loan Loan  3.25  5/9/2018   $5,207,431    5,188,396    5,219,147  

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien) Loan  5.00  3/27/2021   $992,500    988,065    863,475  

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2 Loan  6.00  10/1/2021   $1,000,000    990,433    998,040  

Scitor Corporation

 Services: Business Term Loan Loan  5.00  2/15/2017   $463,977    462,387    461,077  

Seadrill

 Oil & Gas Term Loan B Loan  4.00  2/21/2021   $997,481    917,590    806,294  

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

 Industrial Equipment Term Loan Loan  3.25  5/13/2019   $1,509,445    1,509,445    1,511,603  

Sensus USA Inc. (fka Sensus Metering Systems)

 Utilities Term Loan (First Lien) Loan  4.50  5/9/2017   $1,925,067    1,920,548    1,925,067  

ServiceMaster Company, The

 Conglomerate Tranche B Term Loan Loan  4.25  7/1/2021   $1,995,000    1,976,650    1,994,641  

Shearers Foods LLC

 Food Services Term Loan (First Lien) Loan  4.50  6/30/2021   $997,500    995,166    996,253  

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  5.50  12/10/2020   $225,000    224,471    225,000  

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan Loan  5.50  12/10/2020   $1,275,000    1,272,004    1,275,000  

Sophia, L.P.

 Electronics/Electric Term B Loan Loan  4.00  7/19/2018   $886,138    877,732    884,756  

SourceHOV LLC

 Services: Business Term Loan B (First Lien) Loan  7.75  10/31/2019   $2,000,000    1,942,284    1,915,000  

Southwire Company, LLC (f.k.a Southwire Company)

 Building and Development Initial Term Loan Loan  3.25  2/10/2021   $496,250    495,181    485,084  

SRAM, LLC

 Industrial Equipment Term Loan (First Lien) Loan  4.00  4/10/2020   $2,967,681    2,957,888    2,952,842  

Steak ‘n Shake Operations, Inc.

 Food Services Term Loan Loan  4.75  3/19/2021   $992,500    983,723    975,131  

STHI Holding

 Healthcare & Pharmaceuticals Term Loan Loan  4.50  8/6/2021   $997,500    997,500    994,388  

SunGard Data Systems Inc. (Solar Capital Corp.)

 Conglomerate Tranche C Term Loan Loan  3.90  2/28/2017   $285,352    283,117    285,084  

SunGard Data Systems Inc. (Solar Capital Corp.)

 Conglomerate Tranche E Term Loan Loan  4.00  3/9/2020   $3,707,953    3,618,899    3,706,804  

SuperMedia Inc. (fka Idearc Inc.)

 Publishing Loan Loan  11.60  12/30/2016   $238,660    232,462    203,756  

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan Loan  4.00  4/23/2019   $479,913    476,105    473,314  

TGI Friday’s

 Food Services Term Loan B Loan  5.25  7/15/2020   $267,977    266,768    267,642  

TGI Friday’s

 Food Services Term Loan (Second Lien) Loan  9.25  7/15/2021   $2,000,000    2,016,250    2,000,000  

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B Loan  5.50  10/2/2021   $500,000    496,689    504,790  

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan Loan  3.75  2/28/2020   $4,847,054    4,856,484    4,824,661  

TransFirst

 Financial Intermediaries Term Loan Loan  5.50  11/12/2021   $500,000    495,182    502,815  

TransUnion

 Financial Intermediaries Term Loan Loan  4.00  4/9/2021   $496,250    495,138    493,977  

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

 Containers/Glass Products Term Loan Loan  4.00  5/3/2018   $1,850,000    1,843,008    1,822,250  

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

 Healthcare & Pharmaceuticals New Tranche B Term Loan Loan  4.50  6/6/2019   $487,566    479,874    481,471  

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B Loan  5.25  7/10/2020   $974,167    976,455    975,998  

U.S. Security Associates Holdings, Inc.

 Services: Business Delayed Draw Loan Loan  6.25  7/28/2017   $158,518    157,610    156,734  

U.S. Security Associates Holdings, Inc.

 Services: Business Term B Loan Loan  6.25  7/28/2017   $931,046    926,144    920,572  

United Surgical Partners International, Inc.

 Healthcare & Pharmaceuticals New Tranche B Term Loan Loan  4.75  4/3/2019   $2,431,749    2,408,580    2,431,749  

Univar Inc.

 Chemicals/Plastics Term B Loan Loan  5.00  6/30/2017   $3,844,964    3,844,749    3,813,935  

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan Loan  4.00  3/1/2020   $2,947,446    2,931,982    2,940,549  

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B Loan  3.50  2/13/2019   $2,545,588    2,537,415    2,539,683  

Verint Systems Inc.

 Services: Business Term Loan Loan  3.50  9/6/2019   $1,264,058    1,259,623    1,259,634  

Vertafore, Inc.

 Services: Business Term Loan (2013) Loan  4.25  10/3/2019   $2,881,003    2,881,003    2,878,294  

Vouvray US Finance

 Industrial Equipment Term Loan Loan  5.00  6/28/2021   $497,500    495,243    499,366  

Washington Inventory Service

 Services: Business U.S. Term Loan (First Lien) Loan  5.75  12/20/2018   $1,832,876    1,851,978    1,796,218  

Waste Industries

 Environmental Term Loan B Loan  4.25  2/27/2020   $250,000    249,375    250,520  

Wendy’s International, Inc

 Food Services Term B Loan Loan  3.25  5/15/2019   $673,630    668,099    670,545  

West Corporation

 Telecommunications Term B-10 Loan Loan  3.25  6/30/2018   $2,571,560    2,605,923    2,562,998  
       

 

 

  

 

 

 
$297,760,340  $295,239,268  
       

 

 

  

 

 

 

 

26


Table of Contents

Note 5. Agreements and-Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 8, 2015, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended May 31, 2015 and May 31, 2014, we incurred $1.1 million and $1.0 million in base management fees, respectively. For the three months ended May 31, 2015 and May 31, 2014, we incurred $0.7 million and $0.3 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended May 31, 2015 and May 31, 2014, we accrued of $1.1 million and $0.1 million in incentive fees related to capital gains, respectively. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of May 31, 2015, the base management fees accrual was $1.1 million and the incentive fees accrual was $5.7 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2015, the base management fees accrual was $1.0 million and the incentive fees accrual was $4.8 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two year term of the administration agreement and subsequent renewals. On July 8, 2015, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not been increased since the inception of the agreement, to $1.3 million. In addition, our board of directors intends to review the new cap in the next three to six months to determine whether it should be further adjusted in light of differences between our projected and actual expenses and other similar factors.

 

27


Table of Contents

For the three months ended May 31, 2015 and May 31, 2014, we recognized $0.3 million and $0.3 million in administrator expenses for the periods, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of May 31, 2015 and February 28, 2015, $0.4 million and $0.4 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. For the three months ended May 31, 2015 and May 31, 2014, the Company neither bought nor sold any investments from the Saratoga CLO.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

  expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

  extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

 

28


Table of Contents
  remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

  extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

  reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

  reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of May 31, 2015 and February 28, 2015, there was $11.8 million and $9.6 million outstanding under the Credit Facility, respectively, and the Company was in compliance with all of the limitations and requirements of the Credit Facility. Financing costs of $2.7 million related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.2 million and $0.2 million of interest expense, respectively. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.02 million and $0.1 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. The interest rates during the three months ended May 31, 2015 and May 31, 2014 on the outstanding borrowings under the Credit Facility were 6.00% and 7.50%, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $35.5 million subject to the Credit Facility cap of $45.0 million at May 31, 2015. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the May 31, 2015 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2015. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of May 31, 2015, we have funded SBIC LP with $59.3 million of equity capital, and have $79.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the

 

29


Table of Contents

business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of May 31, 2015 and February 28, 2015, there was $79.0 million and $79.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. Financing costs of $3.0 million related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.6 million and $0.4 million of interest expense related to the SBA debentures, respectively. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the three months ended May 31, 2015 and May 31, 2014 on the outstanding borrowings of the SBA debentures was 3.25% and 3.06%, respectively.

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of May 31, 2015, the carrying amount and fair value of the Notes was $48.3 million and $49.7 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of May 31, 2015, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the three months ended May 31, 2015, we recorded $0.9 million of interest expense and $0.1 million of amortization of deferred financing costs related to the Notes. For the three months ended May 31, 2014, we recorded $0.9 million of interest expense and $0.1 million of amortization of deferred financing costs related to the Notes.

Note 7. Commitments and contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2015:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 -3
Years
   3 -5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $139,100    $—     $  —     $48,300    $90,800  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

30


Table of Contents

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $11.2 million and $11.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of May 31, 2015 and February 28, 2015, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

A summary of the composition of the unfunded commitments as of May 31, 2015 and February 28, 2015 are shown in the table below (dollars in thousands):

 

   As of 
   May 31, 2015   February 28, 2015 

Bristol Hospice, LLC

  $7,500    $7,500  

HMN Holdco, LLC

   2,400     2,400  

Avionte Holdings, LLC

   1,000     1,000  

Knowland Technology Holdings, L.L.C

   300     300  
  

 

 

   

 

 

 

Total

  $11,200    $11,200  
  

 

 

   

 

 

 

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended May 31, 2015 and May 31, 2014, we accrued $0.05 million and $0.05 million for directors’ fees expense, respectively. As of May 31, 2015 and February 28, 2015, $0.04 million and $0.03 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of May 31, 2015, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

 

31


Table of Contents

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. As of February 28, 2015, the Company had not purchased any shares of common stock pursuant to this repurchase plan.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

On May 14, 2015, the Company declared a dividend of $1.00 per share payable on June 5, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

Note 10. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

 

32


Table of Contents

The following information sets forth the computation of the weighted average basic and diluted net decrease in net assets per share from operations for the three months ended May 31, 2015 and May 31, 2014 (dollars in thousands except share and per share amounts):

 

   For the three months ended 

Basic and diluted

  May 31,
2015
   May 31,
2014
 

Net increase in net assets from operations

  $7,385    $1,760  

Weighted average common shares outstanding

   5,422,491     5,379,616  

Earnings per common share-basic and diluted

  $1.36    $0.33  

Note 11. Dividend

On May 14, 2015, the Company declared a dividend of $1.00 per share payable on June 5, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

The following tables summarize dividends declared during the three months ended May 31, 2015 (dollars in thousands except per share amounts):

 

Date Declared

  Record Date  Payment Date  Amount
Per Share*
   Total
Amount
 

May 14, 2015

  May 26, 2015  June 5, 2015  $1.00    $5,429  

April 9, 2015

  May 4, 2015  May 29, 2015  $0.27    $1,466  
      

 

 

   

 

 

 

Total dividends declared

      $1.27    $6,895  
      

 

 

   

 

 

 

 

*Amount per share is calculated based on the number of shares outstanding at the date of declaration.

 

The Company did not declare any dividend payments during the quarter ended May 31, 2014.

Note 12. Financial Highlights

The following is a schedule of financial highlights for the three months ended May 31, 2015 and May 31, 2014:

 

   May 31, 2015  May 31, 2014 

Per share data:

  

Net asset value at beginning of period

  $22.70   $21.08  

Net investment income (1)

   0.33    0.38  

Net realized and unrealized gains and losses on investments and derivatives

   1.03    (0.05
  

 

 

  

 

 

 

Net increase in net assets from operations

   1.36    0.33  

Distributions declared from net investment income

   (1.27  —    
  

 

 

  

 

 

 

Total distributions to stockholders

   (1.27  —    

Other (4)

   (0.04  —    

Net asset value at end of period

  $22.75   $21.41  

Net assets at end of period

  $123,491,324   $115,187,818  

Shares outstanding at end of period

   5,428,758    5,379,616  

Per share market value at end of period

  $17.42   $15.15  

Total return based on market value (2)

   10.86  (4.62)% 

Total return based on net asset value (3)

   1.68  1.57

Ratio/Supplemental data:

  

Ratio of net investment income to average net assets

   5.80  7.28

Ratio of operating expenses to average net assets

   6.65  6.76

 

33


Table of Contents
   May 31, 2015  May 31, 2014 

Ratio of incentive management fees to average net assets

   5.89  1.34

Ratio of credit facility related expenses to average net assets

   6.43  6.31

Ratio of total expenses to average net assets

   18.97  14.40

Portfolio turnover rate (5)

   2.99  4.29

As described in Note 2 to the consolidated financial statements and notes thereto, we identified errors that impacted the three months ended May 31, 2014. The corrections for the errors, which we have concluded are immaterial to all prior period consolidated financial statements, are reflected in the consolidated financial statements included in this Form 10-Q.

 

 

(1)Net investment income per share is calculated using the weighted average shares outstanding during the period.
(2)Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3)Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(4)Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 11, Dividend.
(5)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

Note 13. Subsequent Events

On May 29, 2015, the Company entered into a Debt Distribution Agreement with Landenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the Notes through an At-the-Market (“ATM”) offering. As of July 14, 2015, the Company sold 227,863 bonds with a principal of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).

On July 8, 2015 the Company declared a dividend of $0.33 per share payable for the fiscal quarter ended May 31, 2015 to all stockholders of record at the close of business on August 3, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

 

34


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 28, 2015.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

 

  our future operating results;

 

  our business prospects and the prospects of our portfolio companies;

 

  the impact of investments that we expect to make;

 

  our contractual arrangements and relationships with third parties;

 

  the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

  the ability of our portfolio companies to achieve their objectives;

 

  our expected financings and investments;

 

  our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiary, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

 

  the adequacy of our cash resources and working capital;

 

  the timing of cash flows, if any, from the operations of our portfolio companies; and

 

  the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

 

35


Table of Contents

Corporate History and Recent Developments

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale the 982,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a SBIC license from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. The notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

On May 29, 2015, we entered into a Debt Distribution Agreement with Landenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the Notes through an At-the-Market (“ATM”) offering. As of July 14, 2015, the Company sold 227,863 bonds with a principal of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).

 

36


Table of Contents

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

  An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews each preliminary valuation and Saratoga Investment Advisors and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

37


Table of Contents

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

38


Table of Contents

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

  organization;

 

  calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

  expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

  interest payable on debt, if any, incurred to finance our investments;

 

  offerings of our common stock and other securities;

 

  investment advisory and management fees;

 

  fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

  transfer agent and custodial fees;

 

  federal and state registration fees;

 

  all costs of registration and listing our common stock on any securities exchange;

 

  federal, state and local taxes;

 

  independent directors’ fees and expenses;

 

  costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

 

  costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

  our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

  direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

  administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter, and an incentive fee.

The incentive fee had two parts:

 

  A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

  A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

 

39


Table of Contents

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

  The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

  Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

  We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

New Accounting Pronouncements

In February 2015, the FASB issued ASU 2015-02, Consolidation (ASC Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 significantly changes the consolidation analysis required under GAAP and ends the deferral granted to investment companies from applying the variable interest entity guidance. ASU 2015-02 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2015 and early adoption is permitted. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management is currently evaluating the impact of adopting this new accounting guidance update on the company’s consolidated financial statement.

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statement disclosures.

 

40


Table of Contents

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2016, and early application is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

Portfolio and investment activity

Corporate Debt Portfolio Overview

 

   At May 31,
2015
  At February 28,
2015
 
   ($ in millions)  ($ in millions) 

Number of investments(1)

   65    63  

Number of portfolio companies(1)

   35    34  

Average investment size(1)

  $3.8   $3.5  

Weighted average maturity(1)

   3.5yrs    3.7yrs  

Number of industries(1)

   14    14  

Average investment per portfolio company(1)

  $7.0   $6.6  

Non-performing or delinquent investments(1)

  $0.0   $0.0  

Fixed rate debt (% of interest bearing portfolio)(2)

  $83.0(37.5) $82.5(40.6)

Weighted average current coupon(2)

   11.9  12.0

Floating rate debt (% of interest bearing portfolio)(2)

  $138.2(62.5) $120.8(59.4)

Weighted average current spread over LIBOR(2)

   8.9  8.7

 

(1)Excludes our investment in the subordinated notes of Saratoga CLO and limited partnership interests.
(2)Excludes our investment in the subordinated notes of Saratoga CLO, investments in common stocks and limited partnership interests.

During the three months ended May 31, 2015, we made $23.2 million investments in new or existing portfolio companies and had $7.3 million in aggregate amount of exits and repayments resulting in net investments of $15.9 million for the period.

During the three months ended May 31, 2014, we made $21.6 million investments in new or existing portfolio companies and had $8.7 million in aggregate amount of exits and repayments resulting in net investments of $12.9 million for the period.

Our portfolio composition at May 31, 2015 and February 28, 2015 at fair value was as follows:

Portfolio composition

 

   At May 31, 2015  At February 28, 2015 
   Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
  Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
 

Syndicated loans

   6.8  6.3  7.6  6.2

First lien term loans

   59.8    11.2    60.3    11.0  

Second lien term loans

   15.4    11.0    14.8    11.2  

Unsecured notes

   2.2    10.8    1.8    13.7  

Saratoga CLO subordinated notes

   6.4    28.8    7.1    25.2  

Equity interests

   9.4    N/A    8.4    N/A  
  

 

 

  

 

 

  

 

 

  

 

 

 

Total

   100.0  12.0  100.0  11.8
  

 

 

  

 

 

  

 

 

  

 

 

 

 

41


Table of Contents

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at May 31, 2015 and February 28, 2015, was composed of $306.6 million and $296.9 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO 2013-1 LTD. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility”). We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at May 31, 2015, $301.1 million or 98.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and three Saratoga CLO portfolio investments were in default with a fair value of $1.4 million. At February 28, 2015, $291.6 million or 98.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $2.7 million.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

The CMR distribution of our investments at May 31, 2015 and February 28, 2015 was as follows:

Portfolio CMR distribution

 

   At May 31, 2015  At February 28, 2015 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $211,564     80.5 $191,606     79.7

Yellow

   9,611     3.7    11,635     4.8  

Red

   103     0.0    101     0.0  

N/A(1)

   41,466     15.8    37,196     15.5  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $262,744     100.0 $240,538     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The CMR distribution of Saratoga CLO investments at May 31, 2015 and February 28, 2015 was as follows:

Portfolio CMR distribution

 

   At May 31, 2015  At February 28, 2015 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $284,908     93.5 $278,769     94.4

Yellow

   16,166     5.3    12,875     4.4  

Red

   3,118     1.0    2,978     1.0  

N/A(1)

   491     0.2    617     0.2  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $304,683     100.0 $295,239     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of Saratoga CLO’s equity interests.

 

42


Table of Contents

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at May 31, 2015 and February 28, 2015:

 

   At May 31, 2015  At February 28, 2015 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Software as a Service

  $59,940     22.8 $50,362     20.9

Business Services

   52,494     20.0    52,128     21.7  

Consumer Services

   28,977     11.0    27,332     11.4  

Healthcare Services

   20,027     7.6    20,641     8.6  

Food and Beverage

   17,285     6.6    10,348     4.3  

Structured Finance (1)

   16,860     6.4    17,031     7.1  

Media

   15,494     5.9    15,026     6.2  

Metals

   15,262     5.8    15,262     6.3  

Automotive Aftermarket

   10,540     4.0    10,980     4.6  

Electronics

   6,576     2.5    6,667     2.8  

Publishing

   6,421     2.4    1,985     0.8  

Utilities

   5,955     2.3    5,955     2.5  

Building Products

   3,775     1.5    3,436     1.4  

Consumer Products

   3,035     1.2    3,284     1.4  

Education

   103     0.0    101     0.0  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $262,744     100.0 $240,538     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO.

 

43


Table of Contents

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at May 31, 2015 and February 28, 2015:

 

   At May 31, 2015  At February 28, 2015 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Services: Business

  $42,819     14.1 $42,751     14.4

Healthcare & Pharmaceuticals

   34,030     11.1    35,341     12.0  

Chemicals/Plastics

   26,610     8.7    25,758     8.7  

Conglomerate

   21,103     6.9    19,928     6.7  

Retailers (Except Food and Drugs)

   20,873     6.9    22,026     7.4  

Financial Intermediaries

   16,026     5.3    10,806     3.7  

Industrial Equipment

   14,933     4.9    15,290     5.2  

Electronics/Electric

   12,448     4.1    12,904     4.4  

Leisure Goods/Activities/Movies

   11,587     3.8    12,629     4.3  

Telecommunications

   8,950     2.9    6,675     2.3  

Aerospace and Defense

   8,733     2.9    7,287     2.5  

Automotive

   6,651     2.2    6,650     2.2  

Utilities

   6,243     2.0    6,281     2.1  

Food Products

   5,866     1.9    5,856     2.0  

Lodging and Casinos

   5,702     1.9    5,826     2.0  

Oil & Gas

   5,699     1.9    6,070     2.1  

Publishing

   5,584     1.8    5,627     1.9  

Insurance

   5,415     1.8    5,425     1.8  

Food Services

   5,378     1.8    5,886     2.0  

Brokers/Dealers/Investment Houses

   4,866     1.6    4,832     1.6  

Containers/Glass Products

   4,320     1.4    4,313     1.5  

Drugs

   4,043     1.3    10,091     3.4  

Retail

   4,013     1.3    —       —    

Technology

   3,959     1.3    1,008     0.3  

Media

   3,500     1.1    2,004     0.7  

Food/Drug Retailers

   2,917     1.0    5,861     2.0  

Cable and Satellite Television

   2,632     0.9    2,646     0.9  

Telecommunications/Cellular

   2,425     0.8    2,431     0.8  

Consumer Goods: Durable

   2,114     0.7    —       —    

Nonferrous Metals/Minerals

   1,790     0.6    1,835     0.6  

Hotels, Gaming, and Leisure

   1,010     0.3    —       —    

Consumer Goods: Non-Durable

   995     0.3    —       —    

Services: Consumer

   502     0.2    —       —    

Broadcast Radio and Television

   445     0.1    467     0.2  

Environmental

   251     0.1    250     0.1  

Building and Development

   251     0.1    485     0.2  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

$304,683   100.0$295,239   100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

44


Table of Contents

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at May 31, 2015 and February 28, 2015. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

   At May 31, 2015  At February 28, 2015 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Southeast

  $116,223     44.2 $92,069     38.3

Midwest

   55,152     21.0    55,767     23.2  

West

   39,415     15.0    40,259     16.7  

Northeast

   34,094     13.0    34,412     14.3  

Other(1)

   16,860     6.4    17,031     7.1  

International

   1,000     0.4    1,000     0.4  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

$262,744   100.0$240,538   100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO.

Results of operations

Operating results for the three months ended May 31, 2015 and May 31, 2014 are as follows:

 

   For the three months ended 
   May 31,
2015
   May 31,
2014
 
   ($ in thousands) 

Total investment income

  $7,561    $6,144  

Total expenses, net

   5,790     4,081  
  

 

 

   

 

 

 

Net investment income

 1,771   2,063  

Net realized gains

 73   82  

Net unrealized appreciation/(depreciation) on investments

 5,541   (385
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

$7,385  $1,760  
  

 

 

   

 

 

 

Investment income

The composition of our investment income for the three months ended May 31, 2015 and May 31, 2014 are as follows:

 

   For the three months ended 
   May 31,
2015
   May 31,
2014
 
   ($ in thousands) 

Interest from investments

  $6,931    $5,602  

Management fees from Saratoga CLO

   379     392  

Interest from cash and cash equivalents and other income

   251     150  
  

 

 

   

 

 

 

Total

$7,561  $6,144  
  

 

 

   

 

 

 

For the three months ended May 31, 2015, total investment income increased $1.4 million, or 23.1% compared to the three months ended May 31, 2014. Interest income from investments increased $1.3 million, or 23.7%, to $6.9 million for the three months ended May 31, 2015 from $5.6 million for the three months ended May 31, 2014. This reflects an increase of 20.1% in total investments to $262.7 million at May 31, 2015 from $218.7 million at May 31, 2014, despite the weighted average current coupon reducing from 12.9% to 11.9%.

 

45


Table of Contents

For the three months ended May 31, 2015 and May 31, 2014, total PIK income was $0.7 million and $0.3 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. The management fee income and investment income that we receive from Saratoga CLO has remained relatively unchanged at $0.4 million for the three months ended May 31, 2015 and 2014.

Operating expenses

The composition of our operating expenses for the three months ended May 31, 2015 and May 31, 2014 are as follows:

Operating Expenses

 

   For the three months ended 
   May 31,
2015
   May 31,
2014
 
   ($ in thousands) 

Interest and debt financing expense

  $1,964    $1,787  

Base management fees

   1,124     969  

Professional fees

   333     435  

Incentive management fees

   1,798     378  

Administrator expenses

   250     250  

Insurance

   87     85  

Directors fees and expenses

   51     53  

General & administrative

   183     124  
  

 

 

   

 

 

 

Total expenses

$5,790  $4,081  
  

 

 

   

 

 

 

For the three months ended May 31, 2015, total operating expenses increased $1.7 million, or 41.9% compared to the three months ended May 31, 2014.

For the three months ended May 31, 2015 and May 31, 2014, the increase in interest and credit facility expense is primarily attributable to an increase in outstanding debt as compared to the prior years, with increased levels of both the SBA debentures and the revolving credit facility outstanding. The credit facility increased from $4.7 million at May 31, 2014 to $11.8 million at May 31, 2015, while our SBA debentures increased from $64.0 million to $79.0 million for these same periods. For the three months ended May 31, 2015, the weighted average interest rate on our outstanding indebtedness was 4.94% compared to 5.27% for the three months ended May 31, 2014. This decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate but now make up a higher proportion of our overall debt, increasing from 54.7% of overall debt as of May 31, 2014 to 56.8% as of May 31, 2015.

For the three months ended May 31, 2015, base management fees increased $0.2 million, or 16.1% compared to the three months ended May 31, 2014. The increase in base management fees results from the increase in the average value of our total assets, less cash and cash equivalents, from $219.6 million to $254.8 million as of May 31, 2014 and May 31, 2015, respectively.

For the three months ended May 31, 2015, professional fees decreased $0.1 million, or 23.4% compared to the three months ended May 31, 2014.

For the three months ended May 31, 2015, incentive management fees increased $1.4 million, or 375.0% compared to the three months ended May 31, 2014. These increased fees reflect two factors, being (i) an increase in accrued incentive fees this year, as higher total assets has led to increased net investment income above the hurdle rate pursuant to the investment advisory and management agreement, and (ii) increased second part of the incentive fees of $1.1 million, related primarily to the redemption of one of our investments in which we held both debt and equity, resulting in an unrealized gain of $4.2 million for the three months ended May 31, 2015.

As discussed above, the increase in interest and credit facility expense for three months ended May 31, 2015 and May 31, 2014 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the three months ended May 31, 2015 and May 31, 2014, the weighted average interest rate on the outstanding borrowings under the Credit Facility for three months ended May 31, 2015 and May 31, 2014 was 6.00% and 7.50%, respectively. For three months ended May 31, 2015 and May 31, 2014, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.25% and 3.06%, respectively.

 

46


Table of Contents

Net realized gains/losses on sales of investments

For the three months ended May 31, 2015, the Company had $7.3 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains. The most significant realized gains and losses during the three months ended May 31, 2015 were as follows:

Three Months ended May 31, 2015

 

Issuer

  

Asset Type

  Gross
Proceeds
   Cost   Net
Realized
Gain/
(Loss)
 
      ($ in thousands) 

PrePaid Legal Services, Inc

  First Lien Term Loan   2,091     2,065     26  

Expedited Travel, LLC

  First Lien Term Loan   732     722     10  

For the three months ended May 31, 2014, the Company had $8.7 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains. There were no significant realized gains and losses during the three months ended May 31, 2014.

Net unrealized appreciation/depreciation on investments

For the three months ended May 31, 2015, our investments had net unrealized appreciation of $5.5 million versus net unrealized depreciation of $0.4 million for the three months ended May 31, 2014. The most significant cumulative changes in unrealized appreciation and depreciation for the three months ended May 31, 2015, were the following:

Three Months ended May 31, 2015

 

Issuer

  

Asset Type

  Cost   Fair
Value
   Total
Unrealized
Appreciation/
(Depreciation)
   YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
      ($ in thousands) 

Saratoga CLO

  Other/Structured Finance Securities   15,173     16,860     1,687     609  

Network Communications, Inc.

  Common Stock   —       3,206     3,206     2,906  

Network Communications, Inc.

  Unsecured Notes   2,868     3,214     346     1,297  

Smile Brands Group, Inc.

  First Lien Term Loan   4,366     3,745     (621   (406

The $2.9 million and $1.3 million of unrealized appreciation in our investments in Network Communications, Inc. is due to the sale of the company to a third party and reflects the realization value pursuant to that transaction.

The $0.6 million unrealized appreciation in our investment in the Saratoga CLO was primarily due to a decline in the discount rate based on prevailing market conditions.

The most significant cumulative changes in unrealized appreciation and depreciation for the three months ended May 31, 2014, were the following:

Three Months ended May 31, 2014

 

Issuer

  

Asset Type

  Cost   Fair
Value
   Total
Unrealized
Appreciation/
(Depreciation)
   YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
      ($ in thousands) 

Saratoga CLO

  Other/Structured Finance Securities  $16,556    $20,119    $3,563    $549  

Elyria Foundry Company, LLC

  First Lien Term Loan   8,860     5,721     (3,139   (923

USS Parent Holding Corp.

  Voting Common Stock   3,026     4,510     1,484     (518

The $0.5 million of unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to decline in the discount rate for CLO equity securities from fiscal year end.

 

47


Table of Contents

The $0.9 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a decline in oil and gas end markets from fiscal year end.

The $0.5 million of unrealized depreciation in our investment in the common stock of USS Parent Holding Corp. was due to a decline in the EBITDA multiple from fiscal year end used to determined equity value.

Changes in net assets resulting from operations

For the three months ended May 31, 2015 and May 31, 2014, we recorded a net increase in net assets resulting from operations of $7.4 million and $1.8 million, respectively. Based on 5,422,491 weighted average common shares outstanding as of May 31, 2015, our per share net increase in net assets resulting from operations was $1.36 for the three months ended May 31, 2015. Based on 5,379,616 weighted average common shares outstanding as of May 31, 2014, our per share net increase in net assets resulting from operations was $0.33 for the three months ended May 31, 2014.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. Our stockholders approved a proposal at our annual meeting of stockholders held on September 30, 2014 that authorizes us to sell shares of our common stock at an offering price per share to investors that is not less than 85% of our then current net asset value per share in one or more offerings for a period ending on the earlier of September 30, 2015 or the date of our next annual meeting of stockholders. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after the earlier of September 30, 2015 or our next annual meeting of stockholders.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under Subchapter M of the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 313.8% as of May 31, 2015 and 321.1% as of February 28, 2015. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset

 

48


Table of Contents

and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

  Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

  Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

  Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

 

49


Table of Contents

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

 

  an Interest Coverage Ratio of less than 150.0%;

 

  an Overcollateralization Ratio of less than 175.0%;

 

  the filing of certain ERISA or tax liens;

 

  the occurrence of certain “Manager Events” such as:

 

  failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

 

  failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

  indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

  resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

  occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

 

50


Table of Contents

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

  expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

  extend the Revolving Period from July 30, 2013 to February 24, 2015; and

 

  remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

  extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

  reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

  reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of May 31, 2015, we had $11.8 million outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2015, we had $9.6 million outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at May 31, 2015 and February 28, 2015 was $35.5 million and $36.3 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 313.8% as of May 31, 2015 and 321.1% as of February 28, 2015.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million when it has at least $75 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of May 31, 2015, our SBIC subsidiary had $59.3 million in regulatory capital and $79.0 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

 

51


Table of Contents

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. In connection with the issuance of the notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

 

  we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

 

  we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

On May 29, 2015, we entered into a Debt Distribution Agreement with Landenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the Notes through an ATM offering. As of July 14, 2015, the Company sold 227,863 bonds with a principal of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).

 

52


Table of Contents

At May 31, 2015 and February 28, 2015, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:

 

   At May 31, 2015  At February 28, 2015 
   Fair Value   Percent
of
Total
  Fair Value   Percent
of
Total
 
   ($ in thousands) 

Cash and cash equivalents

  $699     0.3 $1,888     0.7

Cash and cash equivalents, securitization accounts

   5,864     2.2    18,175     7.0  

Syndicated loans

   17,794     6.6    18,302     7.0  

First lien term loans

   157,072     58.3    145,207     55.7  

Second lien term loans

   40,551     15.1    35,603     13.7  

Unsecured notes

   5,861     2.2    4,230     1.7  

Structured finance securities

   16,860     6.2    17,031     6.5  

Equity Interest

   24,606     9.1    20,165     7.7  
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $269,307     100.0 $260,601     100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

On July 8, 2015 the Company declared a dividend of $0.33 per share payable for the fiscal quarter ended May 31, 2015 to all stockholders of record at the close of business on August 3, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

On May 14, 2015, the Company declared a dividend of $1.00 per share payable on June 5, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

Also on September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share payable on December 27, 2013, to common stockholders of record on November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

 

53


Table of Contents

On November 9, 2012, our board of directors declared a dividend of $4.25 per share payable on December 31, 2012, to common stockholders of record on November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share payable on December 31, 2009, to common stockholders of record on November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 8,648,725 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

 

54


Table of Contents

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2015:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 -3
Years
   3 -5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $139,100    $  —     $  —     $48,300    $90,800  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $11.2 million and $11.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of May 31, 2015 and February 28, 2015, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

A summary of the composition of the unfunded commitments as of May 31, 2015 and February 28, 2015 is shown in the table below (dollars in thousands):

 

   As of 
   May 31,
2015
   February 28,
2015
 

Bristol Hospice, LLC

  $7,500    $7,500  

HMN Holdco, LLC

   2,400     2,400  

Avionte Holdings, LLC

   1,000     1,000  

Knowland Technology Holdings, L.L.C

   300     300  
  

 

 

   

 

 

 

Total

$11,200  $11,200  
  

 

 

   

 

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Our market risks have not changed materially from the risks reported in our Form 10-K for the year ended February 28, 2015.

Item 4. Controls and Procedures

 

(a)As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.

 

(b)There have been no changes in our internal control over financial reporting that occurred during the quarter ended May 31, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

55


Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On August 31, 2012, a complaint was filed in the United States Bankruptcy Court for the Southern District of New York by GSC Acquisition Holdings, LLC against us to recover, among other things, approximately $2.6 million for the benefit of the estates and the general unsecured creditors of GSC Group, Inc. and its affiliates, including the Company’s former investment adviser, GSCP (NJ), L.P. The complaint alleges that the former investment adviser made a constructively fraudulent transfer of $2.6 million in deferred incentive fees by waiving them in connection with the termination of the Management Agreement with us, and that the termination of the Management Agreement was itself a fraudulent transfer. These transfers, the complaint alleges, were made without receipt of reasonably equivalent value and while the former investment adviser was insolvent. The complaint has not yet been served, and the plaintiff’s motion for authority to prosecute the case on behalf of the estates was taken under advisement by the court on October 1, 2012. We opposed that motion. We believe that the claims in this lawsuit are without merit and, if the plaintiff is authorized to proceed, intend to vigorously defend against this action.

Except as discussed above, neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

In addition to other information set forth in this report, you should carefully consider the “Risk Factors” discussed in our annual report on Form 10-K filed with the SEC on May 20, 2015 which could materially affect our business, financial condition and/or operating results. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results. There have been no material changes from the risk factors set forth in our Annual Report on Form 10-K for the year ended February 28, 2015.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item  3. Defaults upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item  5. Other Information

Not applicable.

 

56


Table of Contents

Item 6. Exhibits

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

 

Exhibit
Number

  

Description of Document

31.1*  Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2*  Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1*  Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
32.2*  Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

 

*Submitted herewith.

 

57


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

SARATOGA INVESTMENT CORP.
Date: July 14, 2015By:

/s/ CHRISTIAN L. OBERBECK

Christian L. Oberbeck
Chief Executive Officer
By:

/s/ HENRI J. STEENKAMP

Henri J. Steenkamp
Chief Financial Officer and Chief Compliance Officer

 

58